Document:

EXHIBIT 10.29

NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), AND SUCH
SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS SO REGISTERED OR AN
EXEMPTION FROM REGISTRATION UNDER SAID ACT IS AVAILABLE. THIS LEGEND SHALL BE
ENDORSED UPON ANY WARRANT ISSUED IN EXCHANGE FOR THIS WARRANT.

                                WARRANT AGREEMENT

                               FOR COMMON STOCK OF

                                 PROXYMED, INC.

Warrant No. 00-21

         THIS CERTIFIES that, for value received, Commonwealth Associates, L.P.,
or its permitted assigns (collectively, the "Holder"), is entitled to purchase
from ProxyMed, Inc., a Florida corporation (the "Company"), at any time, and
from time to time, during the exercise period referred to in Section 1 hereof
one (1) fully paid, validly issued and nonassessable share (the "Warrant
Shares") of common stock of the Company, par value $0.001 (the "Common Stock")
at the exercise price of $1.00 per share, subject to anti-dilution adjustments
as provided herein (the "Warrant Share Price"). Securities issuable upon
exercise of this Warrant and the exercise price payable therefor are subject to
adjustment from time to time as hereinafter set forth. As used herein, the term
"Warrant" shall include any warrant or warrants hereafter issued in consequence
of the exercise of this Warrant in part or transfer of this Warrant in whole or
in part.

         1. Exercise; Payment for Ownership Interest.

         (a) Upon the terms and subject to the conditions set forth herein, this
Warrant may be exercised in whole or in part by the Holder hereof at any time,
or from time to time, on or after the date hereof and prior to 5 p.m. New York
time on June 15, 2005, but, in any event, no earlier than the date on which the
Company obtains shareholder approval of an increase to the number of authorized
shares of its Common Stock to 75,000,000, by presentation and surrender of this
Warrant to the principal offices of the Company, or at the office of its
Transfer Agent (as hereinafter defined), if any, together with the Purchase Form
annexed hereto, duly executed, and accompanied by payment to the Company of an
amount equal to the Warrant Share Price multiplied by the number of Warrant
Shares as to which this Warrant is then being exercised provided, however, that
in each case, the minimum number of Warrant Shares as to which this Warrant is
being exercised shall not be less than 1,000 Warrant Shares; provided, further,

<PAGE>

that in the event of any merger, consolidation or sale of all or substantially
all the assets of the Company resulting in any distribution to the Company's
shareholders, prior to June 15, 2005, the Holder shall have the right to
exercise this Warrant commencing at such time through June 15, 2005 into the
kind and amount of shares of stock and other securities and property (including
cash) receivable by a holder of the number of shares of Common Stock into which
this Warrant might have been exercisable immediately prior thereto. Any transfer
of Warrant Shares obtained by the Holder in exercise of this Warrant is subject
to the requirement that such securities be registered under the Securities Act
of 1933, as amended (the "1933 Act"), and applicable state securities laws or
exempt from registration under such laws. The Holder of this Warrant shall be
deemed to be a shareholder of the Warrant Shares as to which this Warrant is
exercised in accordance herewith effective immediately after the close of
business on the date on which the Holder shall have delivered to the Company
this Warrant in proper form for exercise and payment by certified or official
bank check or wire transfer of the cash purchase price for the number of Warrant
Shares as to which the exercise is being made, or by delivery to the Company of
securities of the Company having a value equal to the cash purchase price for
such number of Warrant Shares determined in good faith by the Board of Directors
of the Company as of the date of delivery, notwithstanding that the stock
transfer books of the Company shall be then closed or that certificates
representing such Warrant Shares shall not then be physically delivered to the
Holder.

         Notwithstanding anything to the contrary provided herein or elsewhere,
in the event that the Company does not obtain the requisite shareholder approval
referred to in this Section 1(a) prior to January 1, 2001, then the Company
shall be obligated to redeem this Warrant at the election of the Holder at the
cash purchase price equal to $2.00 per share in accordance with the procedure
set forth in Section 3 below.

         (b) All or any portion of the Warrant Share Price may be paid by
surrendering Warrants effected by presentation and surrender of this Warrant to
the Company, or at the office of its Transfer Agent, if any, with a Cashless
Exercise Form annexed hereto duly executed (a "Cashless Exercise"). Such
presentation and surrender shall be deemed a waiver by the Company of the
Holder's obligation to pay all or any portion of the aggregate Warrant Share
Price. Except as provided in Section 3(b) below, in the event of a Cashless
Exercise, the Holder shall exchange its Warrant for that number of shares of
Common Stock determined by multiplying the number of Warrant Shares for which
the Holder desires to exercise this Warrant by a fraction, the numerator of
which shall be the difference between the then current market price per share of
the Common Stock and the Warrant Share Price, and the denominator of which shall
be the then current market price per share of Common Stock. For purposes of any
computation under this Section 1(b), the then current market price per share of
Common Stock at any date shall be deemed to be the average for the ten
consecutive business days immediately prior to the Cashless Exercise of the
daily closing prices of the Common Stock on the principal national securities
exchange on which the Common Stock is admitted to trading or listed, or if not
listed or admitted to trading on any such exchange, the closing prices as

                                       2
<PAGE>

reported by the Nasdaq National Market or, if applicable, the Nasdaq SmallCap
Market, or if not then included for quotation on the Nasdaq National Market or
the Nasdaq SmallCap Market, the average of the highest reported bid and lowest
reported asked prices as reported by the OTC Bulletin Board or the National
Quotations Bureau, as the case may be, or if not then publicly traded, the fair
market price, not less than book value thereof, of the Common Stock as
determined in good faith by the Board of Directors of the Company.

         (c) If this Warrant shall be exercised in part only, the Company shall,
upon surrender of this Warrant for cancellation, execute and deliver a new
Warrant evidencing the rights of the Holder thereof to purchase the balance of
the Warrant Shares purchasable hereunder as to which the Warrant has not been
exercised. If this Warrant is exercised in part, such exercise shall be for a
whole number of Warrant Shares. Upon any exercise and surrender of this Warrant,
the Company (i) will issue and deliver to the Holder a certificate or
certificates in the name of the Holder for the largest whole number of Warrant
Shares to which the Holder shall be entitled and, if this Warrant is exercised
in whole, in lieu of any fractional Warrant Share to which the Holder otherwise
might be entitled, cash in an amount equal to the fair value of such fractional
Warrant Share (determined in such reasonable and equitable manner as the Board
of Directors of the Company shall in good faith determine), and (ii) will
deliver to the Holder such other securities, properties and cash which the
Holder may be entitled to receive upon such exercise, or the proportionate part
thereof if this Warrant is exercised in part, pursuant to the provisions of this
Warrant.

         2. Anti-Dilution Provisions. The Warrant Share Price in effect at any
time and the number and kind of securities issuable upon exercise of this
Warrant and the Warrant Share Price shall be subject to adjustment from time to
time upon happening of certain events as follows:

         2.1 Reorganization, Reclassification, Consolidation, Merger or Sale. If
any capital reorganization, reclassification or any other change of capital
stock of the Company, or any consolidation or merger of the Company with another
person, or the sale or transfer of all or substantially all of its assets to
another person shall be effected in such a way that holders of shares of Common
Stock shall be entitled to receive stock, securities or assets with respect to
or in exchange for their shares of Common Stock, then, as a condition precedent
to such transaction, provision shall be made by the Company, in accordance with
this Section 2.1, whereby the Holder hereof shall in connection with the
consummation of such transaction have the right to purchase and receive, upon
the basis and upon the terms and conditions specified in this Warrant Agreement
and in addition to or in exchange for, as applicable, the Warrant Shares subject
to this Warrant immediately theretofore purchasable and receivable upon the
exercise of the rights represented hereby, such securities or assets as would
have been issued or payable with respect to or in exchange for the aggregate
Warrant Shares immediately theretofore purchasable and receivable upon the
exercise of the rights

                                       3
<PAGE>

represented hereby if exercise of the Warrant had occurred immediately prior to
such reorganization, reclassification, consolidation, merger or sale. The
Company will not effect any such consolidation, merger, sale, transfer or lease
unless prior to the consummation thereof the successor entity (if other than the
Company) resulting from such consolidation or merger or the entity purchasing
such assets shall assume by written instrument (i) the obligation to deliver to
the Holder such securities or assets as, in accordance with the foregoing
provisions, the Holder may be entitled to purchase, and (ii) all other
obligations of the Company under this Warrant. The provisions of this Section
2.1 shall similarly apply to successive consolidations, mergers, exchanges,
sales, transfers or leases. In the event that in connection with any such
capital reorganization or reclassification, consolidation, merger, sale or
transfer, additional shares of Common Stock shall be issued in exchange,
conversion, substitution or payment, in whole or in part, for a security of the
Company other than Common Stock, any such issue shall be treated as an issue of
Common Stock covered by the provisions of Section 2.2 hereof.

         2.2 Stock Dividends and Securities Distributions. If, at any time or
from time to time after the date of this Warrant, the Company shall distribute
to the holders of shares of Common Stock (i) securities (including rights,
warrants, options or another form of convertible securities), (ii) property,
other than cash, or (iii) cash, without fair payment therefor, then, and in each
such case, the Holder, upon the exercise of this Warrant, shall be entitled to
receive such securities, property and cash which the Holder would hold on the
date of such exercise if, on the date of the distribution, the Holder had been
the holder of record of the shares of Common Stock issued upon such exercise
and, during the period from the date of this Warrant to and including the date
of such exercise, had retained such shares of Common Stock and the securities,
property and cash receivable by the Holder during such period, subject, however,
to the Holder agreeing to any conditions to such distribution as were required
of all other holders of shares of Common Stock in connection with such
distribution. If the securities to be distributed by the Company involve rights,
warrants, options or any other form of convertible securities and the right to
exercise or convert such securities would expire in accordance with its terms
prior to the exercise of this Warrant, then the terms of such securities shall
provide that such exercise or convertibility right shall remain in effect until
thirty (30) days after the date the Holder of this Warrant receives such
securities pursuant to the exercise hereof.

         2.3 Other Adjustments. In addition to those adjustments set forth in
Sections 2.1 and 2.2, but without duplication of the adjustments to be made
under such Sections, if the Company:

         (i)      declares or pays a dividend or makes a distribution on its
                  Common Stock in shares of its Common Stock;

         (ii)     subdivides or reclassifies its outstanding shares of Common
                  Stock into a greater number of shares;

                                       4
<PAGE>

         (iii)    combines or reclassifies its outstanding shares of Common
                  Stock into a smaller number of shares;

         (iv)     makes a distribution on its Common Stock in shares of its
                  capital stock other than Common Stock; and/or

         (v)      issues, by reclassification of its Common Stock, any shares of
                  its capital stock;

then the number and kind of Warrant Shares purchasable upon exercise of this
Warrant shall be adjusted so that the Holder upon exercise hereof shall be
entitled to receive the kind and number of Warrant Shares or other securities of
the Company that the Holder would have owned or have been entitled to receive
after the happening of any of the events described above had this Warrant been
exercised immediately prior to the happening of such event or any record date
with respect thereto. An adjustment made pursuant to this Section 2.3 shall
become effective immediately after the record date in the case of a dividend or
distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or issuance. If, as a result of an
adjustment made pursuant to this Section 2.3, the Holder of this Warrant
thereafter surrendered for exercise shall become entitled to receive shares of
two or more classes of capital stock or shares of Common Stock and any other
class of capital stock of the Company, the Board of Directors (whose
determination shall be conclusive and shall be described in a written notice to
all holders of Warrants promptly after such adjustment) shall determine the
allocation of the adjusted Warrant Share Price between or among shares of such
classes of capital stock or shares of Common Stock and such other class of
capital stock.

         The adjustment to the number of Warrant Shares purchasable upon the
exercise of this Warrant described in this Section 2.3 shall be made each time
any event listed in paragraphs (i) through (v) of this Section 2.3 occurs.

         Simultaneously with all adjustments to the number and/or kind of
securities, property and cash under this Section 2.3 to be issued in connection
with the exercise of this Warrant, the Warrant Share Price will also be
appropriately and proportionately adjusted in the manner determined in good
faith by the Board of Directors of the Company.

         In the event that at any time, as a result of an adjustment made
pursuant to this Section 2.3, the Holder of this Warrant thereafter shall become
entitled to receive any shares of the Company, other than Common Stock,
thereafter the number of such other shares so receivable upon exercise of this
Warrant shall be subject to adjustment from time to time in a manner and on
terms as nearly equivalent as practicable to the provisions with respect to the
Common Stock contained in Sections 2.1 and 2.2 above, as most applicable.

                                       5
<PAGE>

         2.4 Sale of Securities. In the event the Company, at any time after the
date of this Warrant, issues additional Common Stock, convertible preferred
stock, options, warrants, or other securities convertible into or exercisable
for Common Stock other than securities currently outstanding as of the date
hereof or issued upon the conversion or exercise of any securities outstanding
as of the date hereof, or pursuant to the Placement Agency Agreement, dated as
of June 7, 2000, by and between the Company and Commonwealth Associates, L.P.
(the "Placement Agency Agreement") in connection with the Private Placement (as
defined in the Placement Agency Agreement), at a purchase price less than (i) in
the case of any such issuance effected or agreed to by the Company prior to June
15, 2001, the Warrant Share Price in effect immediately prior to such issuance
or sale, then the Warrant Share Price shall be automatically reduced to such
lower purchase price and the number of Warrant Shares shall be increased to a
number determined by multiplying the number of Warrant Shares so purchasable
immediately prior to the date of such issuance or sale by a fraction, the
numerator of which shall be the Warrant Share Price in effect immediately prior
to the adjustment required by this Section 2.4 and the denominator of which
shall be the Warrant Share Price in effect immediately after such adjustment or
(ii) if clause (i) is not applicable, (a) the current market price per share of
Common Stock (determined in the manner contemplated by Section 1(b) above) on
the date the Company becomes obligated to make such issuance, or (b) in the case
of any such issuance effected or agreed to by the Company after June 15, 2001,
the Warrant Share Price then effective upon such issuance or sale, the Warrant
Share Price shall be reduced to the price determined by multiplying the Warrant
Share Price in effect immediately prior to such issuance or sale by a fraction,
the numerator of which shall be the sum of (A) the number of shares of Common
Stock outstanding (exclusive of any treasury shares) immediately prior to such
issuance or sale multiplied by the current market price per share of Common
Stock on the date of such issuance or sale (determined in the manner
contemplated by Section 1(b) above), plus (B) the consideration received by the
Company upon such issuance or sale, and the denominator of which shall be the
product of (X) the total number of shares of Common Stock outstanding (exclusive
of any treasury shares) immediately after such issuance or sale, multiplied by
(Y) the current market price per share of Common Stock on the date of such
issuance or sale (determined in the manner contemplated by Section 1(b) above);
and the number of Warrant Shares purchasable upon the exercise of the Warrants
shall be increased to a number determined by multiplying the number of Shares so
purchasable immediately prior to the date of such issuance or sale by a
fraction, the numerator of which shall be the Warrant Share Price in effect
immediately prior to the adjustment required by this Section 2.4 and the
denominator of which shall be the Warrant Share Price in effect immediately
after such adjustment;

provided, however, that no adjustment to the Warrant Share Price or the number
and kind of Warrant Shares shall be made pursuant to this Section 2.4 in the
event (i) the Company grants options to employees, officers, directors or
consultants of the Company pursuant to contracts or plans heretofore approved by
the Board of Directors of the Company, (ii) of the issuance of securities to a
"strategic partner" as determined by the Board of Directors

                                       6
<PAGE>

of the Company, (iii) of the issuance of securities pursuant to a strategic
acquisition as determined by the Board of Directors of the Company, or (iv) of
the issuance of up to an aggregate of 250,000 shares (as appropriately adjusted
for stock splits, stock dividends, and similar adjustments after the Issuance
Date) of Common Stock (or convertible preferred stock, options, warrants or
other securities convertible into or exercisable for Common Stock) at a purchase
price less than the Warrant Share Price and not otherwise excepted pursuant to
clause (i), (ii) and (iii) above.

         (a) For the purpose of making any adjustment in the Warrant Share Price
as provided in this Section 2.4, the consideration received by the Company for
any issue or sale of Common Stock will be computed:

         (i)      to the extent it consists of cash, as the amount of cash
                  received by the Company before deduction of any offering
                  expenses payable by the Company and any underwriting or
                  similar commissions, compensation, or concessions paid or
                  allowed by the Company in connection with such issue or sale;

         (ii)     to the extent it consists of property other than cash, at the
                  fair market value of that property as determined in good faith
                  by the Company's Board of Directors (irrespective of the
                  accounting treatment thereof); and

         (iii)    if Common Stock is issued or sold together with other stock or
                  securities (including convertible preferred stock, options,
                  warrants or securities convertible into or exchangeable for
                  common stock) or other assets of the Company for a
                  consideration which covers both, as the portion of the
                  consideration so received that may be reasonably determined in
                  good faith by the Company's Board of Directors to be allocable
                  to such Common Stock; provided, however, that with respect to
                  such other stock or securities, such consideration as
                  determined by the Company's Board of Directors shall not be
                  less than the total consideration received by the Company for
                  the issuance of such other stock or securities plus the
                  additional aggregate consideration, if any, to be received by
                  the Company upon conversion or exchange thereof.

         (b) If the Company (i) issues, grants or sells any rights or options to
subscribe for, purchase, or otherwise acquire shares of Common Stock, or (ii)
issues or sells any security convertible into shares of Common Stock, then, in
each case, the price per share of Common Stock issuable on the exercise of the
rights or options or the conversion of the securities will be determined by
dividing (x) the total amount, if any,

                                       7
<PAGE>

received or receivable by the Company as consideration for the granting or sale
of the rights or options or the issue or sale of the convertible securities,
plus the minimum aggregate amount of additional consideration payable to the
Company on exercise or conversion of the securities, by (y) the maximum number
of shares of Common Stock issuable on the exercise of conversion. Such granting
or issue or sale will be considered to be an issue or sale for cash of the
maximum number of shares of Common Stock issuable on exercise or conversion at
the price per share determined under this Section 2.4, and the Warrant Share
Price will be adjusted as above provided to reflect (on the basis of that
determination) the issue or sale. No further adjustment of the Warrant Share
Price will be made as a result of the actual issuance of shares of Common Stock
on the exercise of any such rights or options or the conversion of any such
convertible securities.

         (c) Upon the redemption or repurchase of any such securities or the
expiration or termination of the right to convert into, exchange for, or
exercise with respect to, Common Stock, the Warrant Share Price will be
readjusted to such price as would have been obtained had the adjustment made
upon their issuance been made upon the basis of the issuance of only the number
of such securities as were actually converted into, exchanged for, or exercised
with respect to, Common Stock. If the purchase price or conversion or exchange
rate provided for in any such security changes at any time, then, upon such
change becoming effective, the Warrant Share Price then in effect will be
readjusted to such price as would have been obtained had the adjustment made
upon the issuance of such securities been made upon the basis of (i) the
issuance of only the number of shares of Common Stock theretofore actually
delivered upon the conversion, exchange or exercise of such securities, and the
total consideration received therefor, and (ii) the granting or issuance, at the
time of such change, of any such securities then still outstanding for the
consideration, if any, received by the Company therefor and to be received on
the basis of such changed price or rate.

         2.5 Other Action Affecting Warrant Shares. If the Company takes any
action affecting its shares of Common Stock after the date hereof, that would be
covered by Sections 2.1, 2.2 or 2.3 but for the manner in which such action is
taken or structured, which would in any way diminish the value of this Warrant,
then the Warrant Share Price shall be adjusted in such manner as the Board of
Directors of the Company shall in good faith determine to be equitable under the
circumstances.

         2.6 Notice of Adjustments. Upon the occurrence of each adjustment or
readjustment of the Warrant Share Price pursuant to this Section 2, the Company
at its expense will promptly compute such adjustment or readjustment in
accordance with the terms of this Warrant and prepare a certificate setting
forth such adjustment or readjustment, including a statement of the adjusted
Warrant Share Price or adjusted number of shares of Common Stock, if any,
issuable upon exercise of each Warrant, describing the transaction giving rise
to such adjustments and showing in detail the facts upon which such adjustment
or readjustment is based. The Company will forthwith mail,

                                       8
<PAGE>

by first class mail, postage prepaid, a copy of each such certificate to the
Holder of this Warrant at the address of such Holder as shown on the books of
the Company, and to its Transfer Agent.

         2.7 Other Notices. If at any time:

         (a) the Company shall (i) offer for subscription pro rata to the
holders of shares of the Common Stock any additional equity in the Company or
other rights; (ii) pay a dividend in additional shares of the Common Stock or
distribute securities or other property to the holders of shares of the Common
Stock (including, without limitation, evidences of indebtedness and equity and
debt securities); or (iii) issue securities convertible into, or rights or
warrants to purchase, securities of the Company;

         (b) there shall be any capital reorganization or reclassification or
consolidation or merger of the Company with, or sale, transfer or lease of all
or substantially all of its assets to, another entity; or

         (c) there shall be a voluntary or involuntary dissolution, liquidation
or winding up of the Company;

then, in any one or more of said cases, the Company shall give, by first class
mail, postage prepaid, to the Holder of this Warrant at the address of such
Holder as shown on the books of the Company, (a) at least 15 days' prior written
notice of the date on which the books of the Company shall close or a record
shall be taken for such subscription rights, dividend, distribution or issuance,
and (b) in the case of any such reorganization, reclassification, consolidation,
merger, sale, dissolution, liquidation or winding up, at least 15 days' prior
written notice of the date when the same shall take place if no stockholder vote
is required and at least 15 days' prior written notice of the record date for
stockholders entitled to vote upon such matter if a stockholder vote is
required. Such notice in accordance with the foregoing clause (a) shall also
specify, in the case of any such subscription rights, the date on which the
holders of shares of Common Stock shall be entitled to exercise their rights
with respect thereto, and such notice in accordance with the foregoing clause
(b) shall also specify the date on which the holders of shares of Common Stock
shall be entitled to exchange their shares of Common Stock for securities or
other property deliverable upon such reorganization, reclassification,
consolidation, merger, sale, dissolution, liquidation or winding up, as the case
may be. Failure to give the notice referred to herein shall not affect the
validity or legality of the action which should have been the subject of the
notice.

         2.8 Adjustment Calculations. No adjustment in the Warrant Share Price
shall be required unless such adjustment would require an increase or decrease
of at least one cent ($0.01) in such price; provided, however, that any
adjustments which by reason of this Section 2.8 are not required to be made
shall be carried forward and taken into account in any subsequent adjustment
required to be made hereunder. All calculations

                                       9
<PAGE>

under this Section 2 shall be made to the nearest cent or to the nearest
one-hundredth of a share, as the case may be.

         3. Redemption.

         (a) On not less than 30 days' prior written notice (the "Redemption
Notice") to the Holders of the Warrants being redeemed, the Warrants outstanding
on the Redemption Date (as defined below) may be redeemed, at the option of the
Company, at a redemption price of $0.01 per Warrant (the "Redemption Price"),
provided (i) the market price of the Common Stock shall exceed 300% of the then
current Warrant Share Price (the "Target Price") for the 20 consecutive trading
days ending on the fifth trading day prior to the date of the Redemption Notice
(the "Target Period"), subject to adjustment as set forth in Section 2 hereof,
(ii) a registration statement permitting the resale of all the Warrant Shares
filed under the 1933 Act has been declared effective and remains effective from
the date of the Redemption Notice through and including the date fixed for
redemption of the Warrants (the "Redemption Date"), and (iii) the Holders are
not subject to any lock-up agreements or similar restrictions with respect to
the sale or transfer of the Warrants or Warrant Shares.

         (b) The Company shall have the option, and, upon written request of
Commonwealth Associates, L.P. ("Commonwealth Associates") and a committee of the
Holders of the Warrants designated by Commonwealth Associates whose members hold
in the aggregate not less then 20% of the Warrants (the "Warrantholders
Committee"), shall be obligated to redeem the Warrants at the Redemption Price,
on not less than 10 days' written notice in the event that at any time prior to
March 15, 2001, the market price of the Common Stock (as determined in
accordance with Section 1(b) hereof) shall equal or exceed the Target Price,
subject to adjustment as set forth in Section 2 hereof, for the Target Period
and the Company does not have an effective registration statement permitting the
resale of all the Warrant Shares or such Warrant Shares are not free of any
lock-ups, agreements or similar restrictions; provided, however, in such event,
the Warrant Share Price, solely for purposes of the cashless exercise purposes
shall be reduced to a price equal to 10% of the Target Price, and all such
cashless exercises shall be effected assuming that the current market price
equals the Target Price. Notwithstanding anything herein to the contrary,
nothing set forth in this Section 3 shall require the Company to effect the
redemption of this Warrant prior to January 1, 2001.

         (c) If the conditions set forth in Section 3(a) or (b) are met, and the
Company desires to exercise its right to redeem the Warrants, it shall mail a
Redemption Notice to each of the Holders of the Warrants to be redeemed, first
class, postage prepaid, not later than the thirtieth day before the date fixed
for redemption, at their last address as shall appear on the records maintained
pursuant to Section 6(b). Any notice mailed in the manner provided herein shall
be conclusively presumed to have been duly given whether or not the Holder
receives such notice.

                                       10
<PAGE>

         (d) The Redemption Notice shall specify (i) the redemption price, (ii)
the Redemption Date, (iii) the place where the Warrant Certificates shall be
delivered and the redemption price paid, and (iv) that the right to exercise the
Warrant shall terminate at 5:00 P.M. (New York time) on the business day
immediately preceding the Redemption Date. No failure to match such notice nor
any defect therein or in the mailing thereof shall affect the validity of the
proceedings for such redemption except as to a Holder (a) to whom notice was not
mailed or (b) whose notice was defective. An affidavit of the Warrant Agent or
of the Secretary or an Assistant Secretary of the Company that notice of
redemption has been mailed shall, in the absence of fraud, be prima facie
evidence of the facts stated herein.

         (e) Any right to exercise a Warrant shall terminate at 5:00 P.M. (New
York time) on the business day immediately preceding the Redemption Date. On and
after the Redemption Date, Holders of the Warrants shall have no further rights
except to receive, upon surrender of the Warrant, the Redemption Price.

         (f) From and after the Redemption Date, the Company shall, at the place
specified in the Redemption Notice, upon presentation and surrender to the
Company by or on behalf of the Holder thereof of one or more Warrant
Certificates evidencing Warrants to be redeemed, deliver or cause to be
delivered to or upon the written order of such Holder a sum in cash equal to the
Redemption Price of each such Warrant. From and after the Redemption Date and
upon the deposit or setting aside by the Company of a sum sufficient to redeem
all the Warrants called for redemption, such Warrants shall expire and become
void and all rights hereunder and under the Warrant Certificates, except the
right to receive payment of the Redemption Price, shall cease.

         4. No Voting Rights. Except as otherwise provided herein, this Warrant
shall not be deemed to confer upon the Holder any right to vote or to consent to
or receive notice as a stockholder of the Company, as such, in respect of any
matters whatsoever, or any other rights or liabilities as a stockholder, prior
to the exercise hereof.

         5. Warrants Transferable. This Warrant and all rights hereunder are
transferable, in whole or in part, at the principal offices of the Company by
the Holder hereof, upon surrender of this Warrant properly endorsed provided,
however, that in each case the minimum number of Warrant Shares being
transferred by the Holder shall not be less than 1,000 Warrant Shares; provided,
further, that without the prior written consent of the Company, this Warrant and
all rights hereunder may be transferred only (i) to an affiliate of the initial
Holder hereof or successor in interest to any such person in a transaction
exempt from registration under the 1933 Act; or (ii) pursuant to the
registration of this Warrant or the Warrant Shares under the 1933 Act or
subsequent to one year from the date hereof pursuant to an available exemption
from such registration.

         6. Warrants Exchangeable; Assignment; Loss, Theft, Destruction, Etc.
This Warrant is exchangeable, without expense, upon surrender hereof by the
Holder hereof at the principal offices of the Company, or at the office of its
Transfer Agent, if any, for new

                                       11
<PAGE>

Warrants of like tenor representing in the aggregate the right to subscribe for
and purchase the Warrant Shares which may be subscribed for and purchased
hereunder, each such new Warrant to represent the right to subscribe for and
purchase such Warrant Shares as shall be designated by such Holder hereof at the
time of such surrender. Upon surrender of this Warrant to the Company at its
principal office, or at the office of its Transfer Agent, if any, with an
instrument of assignment duly executed and funds sufficient to pay any transfer
tax, the Company shall, without charge, execute and deliver a new Warrant in the
name of the assignee named in such instrument of assignment and this Warrant
shall promptly be cancelled. This Warrant may be divided or combined with other
warrants which carry the same rights upon presentation hereof at the principal
office of the Company, or at the office of its Transfer Agent, if any, together
with a written notice specifying the names and denominations in which new
Warrants are to be issued and signed by the Holder hereof. The term "Warrant" as
used herein includes any Warrants into which this Warrant may be divided or
exchanged. Upon receipt of evidence satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and, in the case of any such
loss, theft or destruction, upon delivery of a bond or indemnity satisfactory to
the Company, or, in the case of any such mutilation, upon surrender or
cancellation of this Warrant, the Company will issue to the Holder hereof a new
Warrant of like tenor, in lieu of this Warrant, representing the right to
subscribe for and purchase the Warrant Shares which may be subscribed for and
purchased hereunder. Any such new Warrant executed and delivered shall
constitute an additional contractual obligation of the Company, whether or not
this Warrant so lost, stolen, destroyed, or mutilated shall be at any time
enforceable by anyone.

         7. Legends; Investment Representations. Any certificate evidencing the
securities issued upon exercise of this Warrant shall bear a legend in
substantially the following form:

                  THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
         REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"),
         AND SUCH SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS SO
         REGISTERED OR AN EXEMPTION FROM REGISTRATION UNDER SAID ACT IS
         AVAILABLE.

         8. Modifications and Waivers. The Holder of this Warrant acknowledges
and agrees that the terms of this Warrant may be amended, modified or waived
only by the written agreement of the Company, Commonwealth Associates and the
Warrantholders Committee; provided, however, that no such amendment,
modification or waiver which would decrease the number of Warrant Shares
purchasable upon the exercise of any Warrant, or increase the Warrant Share
Price therefor (other than as a result of the waiver or modification of any
anti-dilution provisions) may be made without the approval of the holders of at
least 50% of the outstanding Warrants. In connection with the foregoing, the
Company is entitled to rely upon and assume the accuracy and completeness of the
certificate supplied by the Warrantholders Committee and the Company shall not
be

                                       12
<PAGE>

liable to the Holder of this Warrant for any action taken or omitted to be taken
in accordance with and reliance on such certificate.

         9. Miscellaneous. The Company shall pay all expenses and other charges
payable in connection with the preparation, issuance and delivery of this
Warrant and all substitute Warrants. The Holder shall pay all taxes (other than
any issuance taxes, including, without limitation, documentary stamp taxes,
transfer taxes and other governmental charges, which shall be paid by the
Company) in connection with such issuance and delivery of this Warrant and the
Warrant Shares. In addition, the Holder shall pay all taxes in connection with
any sale, assignment or other transfer of this Warrant.

         The Company shall maintain, at the office or agency of the Company
maintained by the Company, books for the registration and transfer of the
Warrant.

         10. Reservation of Warrant Shares. The Company will at all times
reserve and keep available, free from preemptive rights, out of the aggregate of
its authorized but unissued Common Stock or its authorized and issued Common
Stock held in its treasury, solely for the purpose of enabling it to satisfy any
obligation to issue Warrant Shares upon exercise of this Warrant, the maximum
number of shares of Common Stock which may then be deliverable upon the exercise
of this Warrant (subject to, in the case of a deficiency in the number of such
authorized shares, the approval of the Company's shareholders with respect to
the increase in the number of authorized shares of Common Stock from 50,000,000
to 100,000,000).

         The Company or, if appointed, the Transfer Agent for the Common Stock
(the "Transfer Agent") and every subsequent transfer agent for any shares of the
Company's capital stock issuable upon the exercise of any of the rights of
purchase aforesaid will be irrevocably authorized and directed at all times to
reserve such number of authorized shares as shall be required for such purpose.
The Company will keep a copy of this Warrant on file with the Transfer Agent and
with every subsequent transfer agent for any shares of the Company's capital
stock issuable upon the exercise of the rights of purchase represented by this
Warrant. The Company will furnish such Transfer Agent a copy of all notices of
adjustments and certificates related thereto transmitted to the Holder pursuant
to Section 2.6 hereof.

         The Company covenants that all Warrant Shares which may be issued upon
exercise of this Warrant will, upon issue, be fully paid, nonassessable, free of
preemptive rights and free from all taxes, liens, charges and security interests
with respect to the issue thereof.

         11. Registration. The Company agrees to register the Warrant Shares for
resale under the 1933 Act on the terms and subject to the conditions set forth
in the Subscription Agreement between the Company and each of the investors
party thereto.

                                       13
<PAGE>

         12. Descriptive Headings and Governing Law. The descriptive headings of
the several paragraphs of this Warrant are inserted for convenience only and do
not constitute a part of this Warrant. This Warrant shall be construed and
enforced in accordance with the laws of the State of New York, and the rights of
the parties shall be governed by, the law of such State.

                                       14
<PAGE>

         IN WITNESS WHEREOF, this Warrant Agreement has been executed as of the
15th day of June, 2000.

                                           PROXYMED, INC.

                                           By:
                                              ----------------------------------
                                              Name:
                                              Title:

                                       15
<PAGE>

                                  PURCHASE FORM

                                                          Dated:__________, ____

         The undersigned hereby irrevocably elects to exercise the within
Warrant to the extent of purchasing _____ Warrant Shares and hereby makes
payment of $_____________ in payment of the exercise price thereof.

                                      ------------------------------------------

<PAGE>

                                CASHLESS EXERCISE

                                                          Dated:__________, ____

         The undersigned irrevocably elects to exercise the within Warrant for
___ Warrant Shares and hereby makes payment pursuant to the Cashless Exercise
provision of the within Warrant, and directs that the payment of the Warrant
Share Price be made by cancellation as of the date of exercise of a portion of
the within Warrant in accordance with the terms and provisions of Section 1(b)
of the within Warrant.

                                       -----------------------------------------EXHIBIT 10.30

                                 PROXYMED, INC.

                                 ---------------

                             SUBSCRIPTION AGREEMENT

                            Dated as of June 28, 2000

                                 ---------------

                       7% Convertible Senior Secured Notes
                               due January 1, 2001

                   Warrants to Purchase Shares of Common Stock

<PAGE>

                                TABLE OF CONTENTS
<TABLE>
<CAPTION>
                                                                                                              Page No.
                                                                                                              --------
<S>                                                                                                              <C>
ss.1.   ISSUANCE OF SECURITIES....................................................................................2
        ss.1.1.       Authorization...............................................................................2
        ss.1.2.       Subscription for and Sale of Securities; the Closing........................................2
        ss.1.3.       Collateral..................................................................................2
        ss.1.4.       Registration Rights.........................................................................3
        ss.1.5.       Conversion Rights...........................................................................3

ss.2.   REPRESENTATIONS OF THE COMPANY............................................................................4
        ss.2.1.       Organization................................................................................4
        ss.2.2.       Authorization; Enforceability...............................................................4
        ss.2.3.       Capitalization..............................................................................4
        ss.2.4.       Issuances of Securities.....................................................................5
        ss.2.5.       SEC Documents; Financial Statements.........................................................6
        ss.2.6.       Absence of Certain Changes; No Undisclosed Liabilities......................................7
        ss.2.7.       No Solicitation; No Integration of Offering.................................................7
        ss.2.8.       Use of Proceeds; Margin Regulations.........................................................8
        ss.2.9.       Existing Indebtedness.......................................................................8
        ss.2.10.      Investment Company and Holding Company Status...............................................8
        ss.2.11.      Solvency....................................................................................8
        ss.2.12.      Title.......................................................................................9
        ss.2.13.      Intellectual Property Rights................................................................9
        ss.2.14.      Litigation.................................................................................10
        ss.2.15.      Non-Defaults;  Non-Contravention; Etc......................................................10
        ss.2.16.      Taxes......................................................................................11
        ss.2.17.      Compliance With Laws; Licenses; Etc........................................................11
        ss.2.18.      Registration Rights........................................................................11
        ss.2.19.      Title to Securities........................................................................11
        ss.2.20.      Security Interest..........................................................................12
        ss.2.21.      Environmental Laws.........................................................................12
        ss.2.22.      Compliance with ERISA......................................................................12
        ss.2.23.      No Brokers.................................................................................13

ss.3.   REPRESENTATIONS OF THE SUBSCRIBERS.......................................................................13
        ss.3.1.       Investment Purpose.........................................................................13
        ss.3.2.       Accredited Investor Status.................................................................13
        ss.3.3.       Reliance on Exemptions.....................................................................14
</TABLE>

                                     - ii -
<PAGE>

<TABLE>
<CAPTION>
                                                                                                              Page No.
                                                                                                              --------
<S>                                                                                                              <C>
        ss.3.4.       No Governmental Review.....................................................................14
        ss.3.5.       Transfer or Resales........................................................................14
        ss.3.6.       Legends....................................................................................15
        ss.3.7.       Authorization; Enforcement.................................................................15
        ss.3.8.       Residency..................................................................................15
        ss.3.9.       Noteholders, Warrantholders and C Preferred Shareholders Committees........................16
        ss.3.10.      Lock-Up....................................................................................16
        ss.3.11.      Reliance on Documents......................................................................16
        ss.3.12.      Investment Risk............................................................................16

ss.4.   CONDITIONS OF CLOSING....................................................................................17
        ss.4.1.       Representations and Warranties.............................................................17
        ss.4.2.       Performance of Obligations, Etc............................................................17
        ss.4.3.       Transaction Documents......................................................................17
        ss.4.4.       No Default, Etc............................................................................17
        ss.4.5.       Compliance with Laws.......................................................................17
        ss.4.6.       No Litigation, Etc.........................................................................18
        ss.4.7.       Proceedings Satisfactory...................................................................18
        ss.4.8.       Approvals and Consents.....................................................................18
        ss.4.9.       Officer's Certificate......................................................................18
        ss.4.10.      Opinion of Counsel for the Company.........................................................18
        ss.4.11.      Securities.................................................................................18
        ss.4.12.      Other Matters..............................................................................18

ss.4A.  CONDITIONS OF CLOSING....................................................................................18
        ss.4A.1.      Representations and Warranties.............................................................19
        ss.4A.2.      Performance of Obligations, Etc............................................................19
        ss.4A.3.      Transaction Documents......................................................................19
        ss.4A.4.      No Litigation, Etc.........................................................................19
        ss.4A.5.      Approvals and Consents.....................................................................19

ss.5.   PAYMENT OF THE NOTES.....................................................................................19
        ss.5.1.       Principal and Interest Payments............................................................19
        ss.5.2.       Mandatory Reserve for Repayments...........................................................20
        ss.5.3.       No Prepayment..............................................................................20
        ss.5.4.       Surrender of Notes; Notation Thereon.......................................................20
        ss.5.5.       Purchase of Notes..........................................................................20

ss.5A.  CONVERSION...............................................................................................20
        ss.5A.1.      Optional Conversion........................................................................21
</TABLE>

                                    - iii -
<PAGE>

<TABLE>
<CAPTION>
                                                                                                              Page No.
                                                                                                              --------
<S>                                                                                                              <C>
        ss.5A.2.      Mandatory Conversion.......................................................................21
        ss.5A.3.      Mechanics of Conversion....................................................................21
        ss.5A.4.      Cash Payments..............................................................................22
        ss.5A.5.      Stamp Taxes, Etc...........................................................................22

ss.6.   FINANCIAL STATEMENTS AND INFORMATION.....................................................................22

ss.7.   INSPECTION OF PROPERTIES AND BOOKS.......................................................................24
        ss.7.A. REGISTRATION RIGHTS..............................................................................24

ss.8.   AFFIRMATIVE COVENANTS....................................................................................24
        ss.8.1.       Payment of Principal, Interest and Premium; to Keep Books; Reserves........................25
        ss.8.2.       Corporate Existence; Payment of Taxes; Conduct of Business; Maintenance of
                      Properties; Compliance with Laws; Insurance; Books and Records.............................25
        ss.8.3.       Notice of Certain Events...................................................................26

ss.9.   NEGATIVE COVENANTS.......................................................................................27
        ss.9.1.       Business in the Ordinary Course............................................................27
        ss.9.2.       Liquidation, Dissolution...................................................................28
        ss.9.3.       Capitalization, Options and Payments.......................................................28
        ss.9.4.       Sales of Assets............................................................................28
        ss.9.5.       Real Property Acquisitions, Dispositions and Leases........................................28
        ss.9.6.       Redemptions................................................................................28
        ss.9.7.       Indebtedness...............................................................................28
        ss.9.8.       Negative Pledge............................................................................29
        ss.9.9.       Investments................................................................................30
        ss.9.10.      Transactions with Affiliates...............................................................30
        ss.9.11.      Dividends..................................................................................30
        ss.9.12.      Subsidiaries...............................................................................30
        ss.9.13.      Employee Matters...........................................................................30
        ss.9.14.      Accounting, Credit Changes and Banking Arrangements........................................31
        ss.9.15.      Tax Elections..............................................................................31

ss.10.  DEFINITIONS..............................................................................................31
        ss.10.1.      Certain Definitions........................................................................31
        ss.10.2.      Accounting Terms...........................................................................32

ss.11.  EVENTS OF DEFAULT; REMEDIES..............................................................................33
        ss.11.1.      Events of Default Defined..................................................................33
        ss.11.2.      Suits for Enforcement......................................................................35
</TABLE>

                                     - iv -
<PAGE>

<TABLE>
<CAPTION>
                                                                                                              Page No.
                                                                                                              --------
<S>                                                                                                              <C>
        ss.11.3.      Remedies Cumulative........................................................................35
        ss.11.4.      Remedies Not Waived........................................................................35

ss.12.  REGISTRATION, TRANSFER AND EXCHANGE OF NOTES.............................................................35

ss.13.  LOST, ETC., NOTES........................................................................................36

ss.14.  AMENDMENT AND WAIVER.....................................................................................36

ss.15.  HOME OFFICE PAYMENT......................................................................................37

ss.16.  LIABILITIES OF THE SUBSCRIBER............................................................................37

ss.17.  TAXES....................................................................................................37

ss.18.  MISCELLANEOUS............................................................................................38
        ss.18.1.      Certain Fees and Expenses..................................................................38
        ss.18.2.      Indemnification............................................................................38
        ss.18.3.      Board Designees............................................................................38
        ss.18.4.      Further Assurances.........................................................................39
        ss.18.5.      Reliance on and Survival of Representations................................................39
        ss.18.6.      Successors and Assigns.....................................................................39
        ss.18.7.      Communications.............................................................................39
        ss.18.8.      Governing Law..............................................................................40
        ss.18.9.      Voidability for Florida Residents..........................................................40
        ss.18.10.     JURISDICTION AND PROCESS; WAIVER OF JURY TRIAL.............................................40
        ss.18.11.     Counterparts...............................................................................41
        ss.18.12.     Headings...................................................................................41
</TABLE>

                                     - v -
<PAGE>

ANNEX A     -   Registration Rights
ANNEX B     -   Lock-Up
EXHIBIT A   -   Form of Note
EXHIBIT B   -   Form of Warrant
EXHIBIT C   -   Form of General Security Agreement
EXHIBIT D   -   Form of Intellectual Property Security Agreement
EXHIBIT E   -   Form of Articles of Amendment to the Company's Articles of
                Incorporation
EXHIBIT F   -   Opinion of Counsel for the Company

                                     - vi -

<PAGE>

                             SUBSCRIPTION AGREEMENT

         This SUBSCRIPTION AGREEMENT (the "Agreement") is made as of the 28th
day of June, 2000, by and between ProxyMed, Inc., a Florida corporation (the
"Company"), and each of the subscribers who have executed and delivered a
signature page hereto (each a "Subscriber" and, collectively, the
"Subscribers"). Certain defined terms used herein shall have the meaning
ascribed thereto in Section 10 below.

         WHEREAS, subject to the terms and conditions set forth herein, the
Company proposes to issue and sell to the Subscribers (i) up to $15,000,000
aggregate principal amount of the Company's 7% convertible senior secured notes
due January 1, 2001 (the "Notes"), which amount may be increased by exercise of
an overallotment option, first by an additional $7,500,000 aggregate principal
amount of the Notes at the option of Commonwealth Associates, L.P.
("Commonwealth Associates") and then by an additional $7,500,000 aggregate
principal amount of the Notes at the option of the Company, and (ii) five-year
warrants to purchase a number of shares of Common Stock of the Company, par
value $0.001 per share (the "Common Stock"), equal to 50% of the number of
shares of Common Stock issuable upon conversion of the Notes at the Conversion
Price (as defined in Section 1.5 below) (the "Warrant Shares"), at an exercise
price per share equal to such Conversion Price (the "Warrants" and, together
with the Notes, the "Units" or the "Securities");

         WHEREAS, the Company has entered into a Redemption and Exchange
Agreement, dated as of May 4, 2000 (the "Redemption Agreement"), with holders of
$13,000,000 of its $15,000,000 of Series B Convertible Preferred Stock (the
"Series B Preferred Stock"), pursuant to which, among other things, the Company
(i) was required to immediately redeem, and did redeem, $4,000,000 of the Series
B Preferred Stock, and is required to redeem an additional $2,500,000 of the
Series B Preferred Stock on each of June 19, 2000, August 1, 2000, and August
31, 2000, and an additional $1,500,000 of the Series B Preferred Stock on
September 29, 2000, in each case, at a redemption price equal to 116.5% of the
Conversion Amount (as defined in the Company's Restated Articles of
Incorporation, as amended (the "Articles")) and as otherwise provided in the
Redemption Agreement, and (ii) is required to consummate one or more financings
which provide net proceeds to the Company of at least $4,000,000 prior to June
17, 2000, at least $9,000,000 (including any amounts previously raised by the
Company following the date of the Redemption Agreement) prior to July 31, 2000,
and $13,000,000 (including any amounts previously raised by the Company
following the date of the Redemption Agreement) prior to August 30, 2000; and

         WHEREAS, the Company intends to use the proceeds from the issuance of
the Securities to effect the aforementioned redemptions of Series B Preferred
Stock.

                                     - 1 -
<PAGE>

         NOW THEREFORE, the parties hereto, intending to be legally bound,
hereby agree as follows:

         ss.1. ISSUANCE OF SECURITIES.

         ss.1.1. Authorization. The Company has duly authorized (i) the issuance
of up to $30,000,000 aggregate principal amount of the Notes, (ii) the issuance
of the Warrants and the Warrant Shares, (iii) the issuance of the Series C
Preferred Stock (as defined below) upon conversion of the Notes and (iv) the
issuance of Common Stock upon conversion of the Series C Preferred Stock and for
the Notes. Each such Note shall be substantially in the form of Exhibit A hereto
and each such Warrant shall be in the substantially in the form of Exhibit B
hereto. As used herein, the term "Notes" and "Warrants" shall include all notes
and warrants, respectively, originally issued pursuant to this Agreement and the
other agreements referred to herein and all notes and warrants delivered in
substitution or exchange for any of said notes or warrants pursuant to this
Agreement and said other agreements and, where applicable, shall include the
singular number as well as the plural.

         ss.1.2. Subscription for and Sale of Securities; the Closing. Subject
to the terms and conditions set forth herein, each Subscriber hereby subscribes
for and agrees to purchase from the Company such number of Units as is set forth
upon its signature page hereto at a price equal to $100,000 per Unit and the
Company agrees to issue and sell such Units at the Closing to each Subscriber
for said purchase price. The closing of the subscription for and purchase of the
Units hereunder ("Closing") shall take place at the offices of Paul, Hastings,
Janofsky & Walker LLP, 399 Park Avenue, New York, New York, at 10:00 A.M., New
York City time, on June 28, 2000 or on such later Business Day as may be agreed
upon by the Company and the Subscribers (the "Closing Date"). On the Closing
Date, the Company will deliver to each Subscriber one or more Notes and
Warrants, registered in such Subscriber's name or in the name of its nominee, in
any denominations (multiples of $100,000 in the case of Notes, and 50,000 in the
case of Warrants), and in the respective aggregate amounts to be subscribed for
and purchased by each such Subscriber, all as each Subscriber may specify by
timely notice to the Company (or, in the absence of such notice, one Note and
one Warrant registered in its name), duly executed and dated the Closing Date,
against such Subscriber's delivery to the Company by wire transfer to the
Company's Account No. 2090002374739 at First Union National Bank of Florida of
immediately available funds in the amount of the purchase price of such Units
(such delivery shall be deemed to be satisfied by the release from escrow, if
applicable, of the appropriate purchase price as set forth in the Escrow
Agreement, dated June 7, 2000, by and between the Company, Commonwealth
Associates, and American Stock Transfer and Trust Company).

         ss.1.3. Collateral. The Notes shall be secured by a General Security
Agreement and an Intellectual Property Security Agreement, each dated the date
hereof, and in the respective forms of Exhibits C and D hereto (as amended,
modified or supplemented from time to time, the "Security Agreements"), of the
Company in favor of the holders of Notes covering all of the assets of the

                                     - 2 -
<PAGE>

Company therein described (collectively, the "Collateral"), and are entitled to
the benefits thereof. The Security Agreements, the Uniform Commercial Code
financing statements executed by the Company and filed in connection with the
Security Agreement, and any and all other documents executed and delivered by
the Company under which the holders of Notes are granted liens on assets of the
Company are collectively referred to as the "Security Documents."

         ss.1.4. Registration Rights. The Company shall provide for the
registration of the shares of Common Stock issuable upon exercise of the
Warrants and upon conversion of the Notes for resale under the Securities Act of
1933, as amended (the "1933 Act") as provided in Section 7.A. and Annex A
hereto.

         ss.1.5. Conversion Rights. The principal amount of the Notes and
interest thereon shall be converted, at any time and from time to time, at the
option of the holder, but no earlier than the first to occur of (a) the Company
obtaining shareholder approval of the issuance of the Securities or (b)
September 4, 2000, into shares of Common Stock at a per share price equal to
$1.00, subject to anti-dilution adjustments as provided herein and in the Series
C Designation (as defined below) and the Notes, as applicable (the "Conversion
Price "), as provided in Section 5A below. In addition, the principal amount of
the Notes, and any accrued interest thereon, automatically shall be converted
into shares (the "C Preferred Shares") of series C 7% convertible preferred
stock of the Company (the "Series C Preferred Stock") having the rights and
preferences set forth in the Article of Amendment to the Company's Articles of
Incorporation in the form attached hereto as Exhibit F (the "Series C
Designation") at the rate specified in Section 5A.2 of this Agreement and the
Note upon the full redemption of the Series B Preferred Stock in accordance with
the terms of the Redemption Agreement. In the event of an Event of a Default (as
hereinafter defined) under the Notes, the Conversion Price shall be decreased,
if lower, to a price equal to the lesser of (i) the lowest price at which any
shares of Series B Preferred Stock may convert into Common Stock, (ii) the
lowest exercise price of the warrants issued to any holder of Series B Preferred
Stock , (iii) 50% of the Conversion Price in effect at the time of the
occurrence of such Event of Default, or (iv) the current market price per share
of Common Stock for the ten (10) Business Days immediately following the date
that the Company first publicly discloses or announces the occurrence of such
Event of Default. For purposes of any computation under this Section 1.5, the
then current market price per share of Common Stock shall be the daily closing
price of the Common Stock on the principal national securities exchange on which
the Common Stock is admitted to trading or listed, or if not listed or admitted
to trading on any such exchange, the closing prices as reported by the Nasdaq
National Market or, if applicable, the Nasdaq SmallCap Market, or if not then
included for quotation on the Nasdaq National Market or the Nasdaq SmallCap
Market, the average of the highest reported bid and lowest reported asked prices
as reported by the OTC Bulletin Board or the National Quotations Bureau, as the
case may be, or if not then publicly traded, the fair market price, not less
than book value thereof, of the Common Stock as determined in good faith by the
Board of Directors of the Company.

                                     - 3 -
<PAGE>

         ss.2. REPRESENTATIONS OF THE COMPANY. As a material inducement to the
Subscribers to subscribe for and purchase the Securities as provided hereunder,
the Company represents and warrants to each Subscriber on the date hereof and on
the Closing Date as follows:

         ss.2.1. Organization. The Company and its Subsidiaries are corporations
duly organized and validly existing in good standing under the laws of the
jurisdiction in which they are incorporated, and have the requisite corporate
power and authority to own their properties and to carry on their business as
now being conducted and as described in the Memorandum and the SEC Documents (as
defined below). Each of the Company and its Subsidiaries is duly qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which its ownership of property or the nature of the business conducted by it
makes such qualification necessary, except to the extent that the failure to be
so qualified or be in good standing would not have a Material Adverse Effect. As
used in this Agreement, "Material Adverse Effect" means any material adverse
effect on the business, properties, assets, operations, results of operations or
financial condition of the Company and its Subsidiaries taken as a whole, or on
the transactions contemplated hereby or by the agreements and instruments to be
entered into in connection herewith, or on the authority or ability of the
Company to perform its obligations under the Transaction Documents (as defined
below). A complete list of entities in which the Company, directly or
indirectly, owns capital stock or holds an equity or similar interest is set
forth in Schedule 2.1.

         ss.2.2. Authorization; Enforceability. The Company has the power to
execute, deliver and perform its obligations under this Agreement and the Notes,
the Warrants, and the Security Documents (collectively, the "Transaction
Documents"), and has taken all necessary corporate action to authorize the
execution, delivery and performance by it of this Agreement and each of the
Transaction Documents and to consummate the transactions contemplated hereby and
thereby, and no other proceedings on the part of the Company or its stockholders
are necessary therefor. The Company has duly executed and delivered this
Agreement and each of the Transaction Documents. This Agreement constitutes, and
each of the Transaction Documents when executed and delivered at Closing as
contemplated hereby will constitute, assuming due execution by the other parties
hereto and thereto, legal, valid and binding obligations of the Company
enforceable against the Company in accordance with their terms and, in each
case, will not be subject to preemptive or any other similar rights of the
shareholders of the Company.

         ss.2.3. Capitalization. As of May 31, 2000, the authorized capital
stock of the Company consists of (i) 50,000,000 shares of Common Stock, of which
as of the date hereof 19,734,429 shares are issued and outstanding, 2,258,167
shares are issuable and reserved for issuance pursuant to the Company's stock
option and purchase plans, 2,628,670 shares are issuable and reserved for
issuance pursuant to warrants issued by the Company to the holders of the Series
B Preferred Stock, and 967,933 shares are issuable and reserved for issuance
pursuant to securities (other than the shares of the Company's Series B
Preferred Stock, and shares of Common Stock issuable pursuant to any Conversion
Notice (as defined in the Company's Articles of Amendment

                                     - 4 -
<PAGE>

to the Company's Articles of Incorporation filed on December 23, 1999) delivered
to the Company on or prior to the date hereof) exercisable or exchangeable for,
or convertible into, shares of Common Stock and (ii) 2,000,000 shares of
preferred stock, of which as of the date hereof 15,000 shares are designated as
Series B Preferred Stock, of which 9,310 shares are issued and outstanding. All
of such outstanding shares have been and are, validly issued, fully paid and
non-assessable. Except as disclosed in Schedule 2.3, (i) no shares of the
Company's capital stock are subject to preemptive rights or any other similar
rights or any liens or encumbrances suffered or permitted by the Company; (ii)
there are no outstanding debt securities issued by the Company; (iii) there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its
Subsidiaries, or contracts, commitments, understandings or arrangements by which
the Company or any of its Subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its Subsidiaries or
options, warrants, scrip, rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities or rights convertible into, any
shares of capital stock of the Company or any of its Subsidiaries; (iv) there
are no agreements or arrangements under which the Company or any of its
Subsidiaries is obligated to register the sale of any of their securities under
the 1933 Act; (v) there are no outstanding securities of the Company or any of
its Subsidiaries which contain any redemption or similar provisions, and there
are no contracts, commitments, understandings or arrangements by which the
Company or any of its Subsidiaries is or may become bound to redeem a security
of the Company or any of its Subsidiaries; (vi) there are no securities or
instruments containing anti-dilution or similar provisions that will be
triggered by the issuance of the Securities; and (vii) the Company does not have
any stock appreciation rights or "phantom stock" plans or agreements or any
similar plan or agreement. All prior sales of securities of the Company were
either registered under the 1933 Act and applicable state securities laws or
exempt from such registration, and no security holder has any rescission rights
with respect thereto.

         ss.2.4. Issuances of Securities. At least 15,000,000 shares of Common
Stock (the "Warrant Shares") have been duly authorized and reserved for issuance
upon exercise of the Warrants, at least 30,000,000 shares of Common Stock have
been duly authorized and reserved for issuance upon conversion of the Notes and
the C Preferred Shares (collectively the "Conversion Shares"), the foregoing
subject to obtaining the approval of the Company's shareholders with respect to
the increase in the number of authorized shares of Common Stock from 50,000,000
to 100,000,000, and at least 300,000 shares of C Preferred Shares have been duly
authorized and reserved for issuance upon conversion of the Notes (in each case,
except for the number of the C Preferred Shares issued upon conversion of the
Notes, subject to adjustment as provided in this Agreement or in any Transaction
Document). Upon exercise or conversion in accordance with the Notes, the
Warrants and the C Preferred Shares, as the case may be, the Warrant Shares and
the Conversion Shares will be validly issued, fully paid and nonassessable, free
from all taxes, liens and charges with respect to the issuance thereof, and not
subject to preemptive or any other similar rights of the shareholders of the
Company, with the holders thereof being entitled to all rights accorded to

                                     - 5 -
<PAGE>

a holder of Common Stock. The issuance by the Company of the Securities is
exempt from registration under the 1933 Act. The issuance by the Company of the
Securities is being made in reliance upon the exemption from registration set
forth in Rule 506 of Regulation D under the 1933 Act and is only being made to
"accredited investors" that meet the requirements of Rule 501(a) of Regulation D
and similar exemptions under state law.

         ss.2.5. SEC Documents; Financial Statements. Since December 31, 1999,
the Company has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the Securities and Exchange Commission
(the "SEC") pursuant to the reporting requirements of the Securities Exchange
act of 1934, as amended (the "1934 Act") (all of the foregoing filed after
December 31, 1999 and prior to the date hereof and all exhibits included therein
and financial statements and schedules thereto and documents incorporated by
reference therein being hereinafter referred to as the "SEC Documents"). A
complete list of the Company's SEC Documents is set forth on Schedule 2.5. As of
their respective dates, the SEC Documents (and in the Memorandum) complied in
all material respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents.
None of the SEC Documents, at the time they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. As of their respective dates, the financial statements of the
Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements of the SEC with respect
thereto. Such financial statements have been prepared in accordance with
generally accepted accounting principles, consistently applied ("GAAP"), during
the periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or
summary statements), show all material liabilities, absolute or contingent, of
the Company required to be required to be recorded thereon, and fairly present
in all material respects the financial position of the Company as of the dates
thereof and the results of its operations and cash flows for the periods
indicated (subject, in the case of unaudited statements, to normal year-end
audit adjustments). The Company meets the requirements for the use of Form S-3
for registration of the resale of the Warrant Shares and Conversion Shares.

         The Company has delivered to each Subscriber a copy of the private
placement memorandum, dated June 6, 2000, prepared by the Company (the
"Memorandum") and, relating to, among other things, the transactions
contemplated hereby. The SEC Documents and the Memorandum, taken together,
fairly and correctly summarize in all material respects the business and
operations of the Company.

         As of their respective dates none of this Agreement, the Memorandum or
any other document, certificate or written statement furnished to the
Subscribers by or on behalf of the Company in connection with the transactions
contemplated hereby contained any untrue statement

                                     - 6 -
<PAGE>

of a material fact or omitted to state any material fact necessary in order to
make the statements therein, in light of the circumstances under which they were
made, not misleading.

         ss.2.6. Absence of Certain Changes; No Undisclosed Liabilities. Except
as specifically disclosed in the SEC Documents filed with the SEC prior to the
date hereof, since December 31, 1999, there have been no material adverse
changes in the financial condition, business, properties or prospects of the
Company or of the Company and its Subsidiaries, taken as a whole, other than
changes referred to in SEC Documents filed subsequent to December 31, 1999 (but
prior to the date hereof) or the Memorandum which have had a Material Adverse
Effect. Except as set forth in Schedule 2.6, the Company does not know of any
fact (other than matters of a general economic nature) which materially affects
adversely or, so far as the Company can now foresee, will materially affect
adversely the financial condition, business, properties or prospects of the
Company, or of the Company and its Subsidiaries taken as a whole, or the ability
of the Company to perform its obligations under this Agreement. Since December
31, 1999, except with respect to matters of which the Company has notified the
Subscribers in writing or which have been specifically disclosed in SEC
Documents filed with the SEC prior to the date hereof, the Company has not
incurred any liabilities or obligations, direct or contingent, not in the
ordinary course of business, or entered into any transaction not in the ordinary
course of business, which is material to the business of the Company, and,
except as set forth in Schedule 2.6 to this Agreement there has not been any
change in the capital stock of, or any incurrence of long-term debt by, the
Company, or any issuance of options, warrants or other rights to purchase the
capital stock of the Company, or any adverse change or any development
involving, so far as the Company can now reasonably foresee, a prospective
adverse change in the condition (financial or otherwise), net worth, results of
operations, business, key personnel or properties which would be material to the
business or financial condition of the Company, and the Company has not become a
party to, and neither the business nor the property of the Company has become
the subject of, any material litigation whether or not in the ordinary course of
business.

         ss.2.7. No Solicitation; No Integration of Offering. Neither the
Company, nor any of its Affiliates, nor any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the 1933 Act) in connection with the
offer or sale of the Securities. Except as to Commonwealth Associates, neither
the Company, nor any of its Affiliates, nor any person acting on its or their
behalf, has paid or given, either directly or indirectly, any commission or
other remuneration to any person for any transaction contemplated by this
Agreement. Neither the Company, nor any of its Affiliates, nor any person acting
on its or their behalf has, directly or indirectly, made any offers or sales of
any security or solicited any offers to buy any security, under circumstances
that would require registration of any of the Securities under the 1933 Act or
cause this offering of Securities to be integrated with prior offerings by the
Company for purposes of the 1933 Act or any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of
the Nasdaq National Market, nor will the Company or any of its Subsidiaries take
any action or steps that would require

                                     - 7 -
<PAGE>

registration of the Securities under the 1933 Act or cause the offering of the
Securities to be integrated with other offerings.

         ss.2.8. Use of Proceeds; Margin Regulations. The Company will apply the
proceeds of the sale of the Notes to effect the redemption of Preferred Stock as
contemplated by the Redemption Agreement and to repay indebtedness to
Transamerica Business Credit Corporation under an existing credit facility, both
as described in the Memorandum. No part of the proceeds from the sale of the
Notes hereunder will be used, directly or indirectly, for the purpose of buying
or carrying any margin stock within the meaning of Regulation G of the Board of
Governors of the Federal Reserve System (12 CFR 207), or for the purpose of
buying or carrying or trading in any securities under such circumstances as to
involve the Company in a violation of Regulation X of said Board (12 CFR 224) or
to involve any broker or dealer in a violation of Regulation T of said Board (12
CFR 220). The assets of the Company and its Subsidiaries do not include any
margin stock, and neither the Company nor any Subsidiary has any present
intention of acquiring any margin stock. As used in this Section, the terms
"margin stock" and "purpose of buying or carrying" shall have the meanings
assigned to them in said Regulation G.

         ss.2.9. Existing Indebtedness. Schedule 2.9 is a complete and correct
list of all debt and other indebtedness of the Company and its Subsidiaries in
an unpaid principal amount exceeding $50,000, showing as to each item of such
indebtedness the obligor, the aggregate principal amount outstanding, a brief
description of any security therefor and whether such indebtedness will be
outstanding on the Closing Date (after giving effect to the application of the
proceeds of the sale of the Notes as provided in ss.2.8). Neither the Company
nor any Subsidiary is in default in the performance or observance of any of the
terms, covenants or conditions contained in any instrument evidencing any such
indebtedness and no event has occurred and is continuing which, with notice or
the lapse of time or both, would become such a default.

         ss.2.10. Investment Company and Holding Company Status. The Company is
not an investment company or a person directly or indirectly controlled by or
acting on behalf of an investment company within the meaning of the Investment
Company Act of 1940, as amended. Neither the Company nor any of its Subsidiaries
is a "holding company" or "subsidiary company" of a "holding company", or an
"affiliate" of a "holding company" or of a "subsidiary company" of a "holding
company", or a "public utility", within the meaning of the Public Utility
Holding Company Act of 1935, as amended.

         ss.2.11. Solvency. The Company (taken as a whole with its Subsidiaries)
is, and upon giving effect to the issuance of the Securities on the Closing Date
will be, Solvent (as defined below). "Solvent" means, that as of the date of
determination (i) the then fair saleable value of the property of such person is
(y) greater than the total amount of liabilities (including guaranties and other
contingent liabilities) of such entity and (z) greater than the amount that will
be required to pay such entity's liability on such entity's existing debts as
they become absolute and matured, (ii) such

                                     - 8 -
<PAGE>

entity does not have unreasonably small capital for the conduct of its business,
and (iii) such entity does not intend to or believe that it will incur debts
beyond its ability to pay such debts as they mature.

         ss.2.12. Title. Except as set forth in or contemplated by Schedule 2.12
to this Agreement, the Company and each Subsidiary has good and marketable title
to all material properties and assets owned by it, free and clear of all liens,
charges, encumbrances or restrictions, except such as are not material or
important in relation to the Company's business; all of the material leases and
subleases under which the Company or any Subsidiary is the lessor or sublessor
of properties or assets or under which the Company holds properties or assets as
lessee or sublessee are in full force and effect, and neither the Company nor
any Subsidiary is in default in any material respect with respect to any of the
terms or provisions of any of such leases or subleases, and no material claim
has been asserted by anyone adverse to rights of the Company or any Subsidiary
as lessor, sublessor, lessee or sublessee under any of the leases or subleases
mentioned above, or affecting or questioning the right of the Company or any
Subsidiary to continued possession of the leased or subleased premises or assets
under any such lease or sublease. The Company owns or leases all such properties
as are necessary to its operations as described in the SEC Documents and the
Memorandum.

         ss.2.13. Intellectual Property Rights. The Company and its Subsidiaries
own or possess adequate rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent
rights, copyrights, inventions, licenses, approvals, governmental
authorizations, trade secrets and rights necessary to conduct their respective
businesses as now conducted and as described in the Memorandum. Except as set
forth on Schedule 2.13, none of the Company's trademarks, trade names, service
marks, service mark registrations, service names, patents, patent rights,
copyrights, inventions, licenses, approvals, government authorizations, trade
secrets or other intellectual property rights have expired or terminated, or are
expected to expire or terminate within two years from the date of this
Agreement, except where such expiration or termination would not have either
individually or in the aggregate a Material Adverse Effect. The Company and its
Subsidiaries do not have any knowledge of any infringement by the Company or its
Subsidiaries of trademarks, trade name rights, patents, patent rights,
copyrights, inventions, licenses, service names, service marks, service mark
registrations, trade secrets or other similar rights of others, or of any such
development of similar or identical trade secrets or technical information by
others and, except as set forth on Schedule 2.13, no claim, action or proceeding
has been made or brought against, or to the Company's knowledge, has been
threatened against, the Company or its Subsidiaries regarding trademarks, trade
name rights, patents, patent rights, inventions, copyrights, licenses, service
names, service marks, service mark registrations, trade secrets or other
infringement. Except as set forth on Schedule 2.13, the Company and its
Subsidiaries are unaware of any facts or circumstances which might give rise to
any of the foregoing. The Company and its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value

                                     - 9 -
<PAGE>

of all of their intellectual properties except where the failure to do so would
not have either individually or in the aggregate a Material Adverse Effect.

         ss.2.14. Litigation. Except as set forth in or contemplated by Schedule
2.14 to this Agreement, there is no material action, suit, investigation,
customer complaint, claim or proceeding at law or in equity by or before any
court, arbitrator, governmental instrumentality or authority or other agency now
pending or, to the knowledge of the Company, threatened against the Company (or
basis therefor known to the Company), the adverse outcome of which would be
reasonably likely to have a Material Adverse Effect. The Company is not subject
to any judgment, order, writ, injunction or decree of any Federal, state,
municipal or other governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign which have a Material Adverse Effect.

         ss.2.15. NonDefaults; NonContravention; Etc. Except as disclosed in
Schedule 2.15, neither the execution, delivery and performance of this Agreement
or the Transaction Documents, nor the consummation by the Company of the
transactions contemplated hereby and thereby, will (i) result in a violation of
the Articles of Incorporation, any articles of amendment of any outstanding
series of preferred stock of the Company or the By-laws; (ii) conflict with, or
constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its Subsidiaries is a party; or (iii)
result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations and the rules and
regulations of the principal market or exchange on which the Common Stock is
traded or listed) applicable to the Company or any of its Subsidiaries or by
which any property or asset of the Company or any of its Subsidiaries is bound
or affected. Except as disclosed in Schedule 2.15, neither the Company nor its
Subsidiaries is in violation of any term of (i) its Articles of Incorporation,
any articles of amendment of any outstanding series of preferred stock or its
By-laws or their organizational charter or by-laws, respectively, or (ii) any
statute, rule or regulation applicable to the Company or its Subsidiaries and
neither the Company nor its Subsidiaries is in default under any contract,
agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or
order, except for such violations or defaults which would not, individually or
in the aggregate, have a Material Adverse Effect. Except as specifically
contemplated by this Agreement and except such as have been obtained as of the
date hereof, the Company is not required to obtain any consent, authorization or
order of, or make any filing or registration with, any court or governmental
agency or any regulatory or self-regulatory agency in order for it to execute,
deliver or perform any of its obligations under or contemplated by this
Agreement or the Transaction Documents in accordance with the terms hereof or
thereof. Except as disclosed in Schedule 2.15, the Company is not in violation
of the listing requirements of the Nasdaq National Market as in effect on the
date hereof and has no actual knowledge of any facts which would reasonably lead
to delisting or suspension of the Common Stock by the Nasdaq National Market in
the foreseeable future.

                                     - 10 -
<PAGE>

         ss.2.16. Taxes. Except as set forth in or contemplated by Schedule 2.16
to this Agreement, the Company has filed all Federal, state, local and foreign
tax returns which are required to be filed by it or otherwise met its disclosure
obligations to the relevant agencies and all such returns are true and correct
in all material respects. The Company has paid or adequately provided for all
tax liabilities of the Company as reflected on such returns or determined to be
due on such returns or pursuant to any assessments received by it or which it is
obligated to withhold from amounts owing to any employee, creditor or third
party. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company know of no
basis for any such claim. The Company has properly accrued all taxes required to
be accrued by GAAP consistently applied. To the best of the Company's knowledge,
the tax returns of the Company have never been audited by any state, local or
Federal authorities. The Company has not waived any statute of limitations with
respect to taxes or agreed to any extension of time with respect to any tax
assessment or deficiency.

         ss.2.17. Compliance With Laws; Licenses; Etc. The business of the
Company and its Subsidiaries is not being conducted, and shall not be conducted,
in violation of any law, ordinance or regulation of any governmental entity
except for such violations the sanctions for which either individually or in the
aggregate would not have a Material Adverse Effect, and the Company has not
received notice of any violation of or noncompliance with any Federal, state,
local or foreign, laws, ordinances, regulations and orders applicable to its
business which has not been cured, the violation of, or noncompliance with
which, would be reasonably likely to have a Material Adverse Effect. The Company
has all material licenses and permits and other governmental certificates,
authorizations and permits and approvals (collectively, "Licenses") required by
every Federal, state and local government or regulatory body for the operation
of its business as currently conducted and the use of its properties, except
where the failure to be licensed or possess a permit would not have a Material
Adverse Effect. The Licenses are in full force and effect and to the Company's
knowledge no violations currently exist in respect of any License and no
proceeding is pending or threatened to revoke or limit any thereof.

         ss.2.18. Registration Rights. Except with respect to holders of the
Notes and the Warrants, and except as set forth in Schedule 2.18 hereto, no
person has any right to cause the Company to effect the registration under the
1933 Act of any securities of the Company. The Company shall grant registration
rights under the 1933 Act to the Subscribers as described in Sections 1.4. and
7.A. and Annex A hereto.

         ss.2.19. Title to Securities. When the Notes and the Warrants have been
duly delivered to the Subscribers, respectively, and payment shall have been
made therefor, each such Subscriber shall receive from the Company good and
marketable title to such securities free and clear of all liens, encumbrances
and claims whatsoever (with the exception of claims arising through the acts or
omissions of the Subscribers and except as arising from applicable Federal and
state securities laws), and the Company shall have paid all taxes, if any, in
respect of the original issuance

                                     - 11 -
<PAGE>

thereof. All Common Stock or C Preferred Shares, as the case may be, which may
be issued upon conversion of the Notes will, upon issuance, be duly issued,
fully paid and non-assessable and free from all taxes, liens, and charges with
respect to the issuance thereof.

         ss.2.20. Security Interest. Except as set forth in Schedule 2.20, the
Security Documents create and grant to the holders of Notes a legal, valid and
perfected security interest in the Collateral. The Collateral is not subject to
any other Lien or security interest whatsoever except as specifically stated in
Schedule 2.20.

         ss.2.21. Environmental Laws. All operating facilities and property
owned, leased, used or operated by the Company or any Subsidiary have been, and
continue to be, owned, leased, used or operated by the Company and such
Subsidiary in compliance with all applicable environmental laws, regulations and
guidelines except where such failure to comply would not have a Material Adverse
Effect. Except as disclosed in Schedule 2.21, there has been no claim,
complaint, notice or request for information received by the Company or any
Subsidiary with respect to environmental matters, including but not limited to,
any alleged violation of any federal, state or local statute, regulation or
ordinance relating to the environment, and there has been no complaint, notice
or inquiry to the Company or any Subsidiary regarding potential liability under
the Comprehensive Environmental Response Compensation and Liability Act, as
amended ("CERCLA"), the Resource Conservation and Recovery Act, as amended, the
Federal Water Pollution Control Act (the "FWPCA"), or any comparable state or
local law. Except as disclosed in Schedule 2.21, there has been no release of a
Hazardous Substance by the Company or any Subsidiary in a quantity in excess of
the current reportable quantity established pursuant to the FWPCA or CERCLA. As
used in this Section, "release" has the meaning assigned to it under CERCLA.

         ss.2.22. Compliance with ERISA. No Plan had a material accumulated
funding deficiency (as such term is defined in Section 302 of ERISA or Section
412 of the Code), whether or not waived, as of the last day of the most relevant
Plan year heretofore ended nor, as of the Closing Date, has the Company or any
ERISA Affiliate failed to make any payments required under Section 302 of ERISA
or Section 412 of the Code to any such Plan. No material liability to the PBGC
(other than required insurance premiums, all of which have been paid) has been
incurred with respect to any Plan which has not been paid in full. There has not
been any reportable event (within the meaning of Section 4073 of ERISA and the
regulations promulgated thereunder)other than a reportable event for which the
30-day notice requirement with respect to such event has been waived by the PBGC
or, to the best of the Company's knowledge, any other event or condition, which
presents a material risk of termination of any such Plan by the PBGC, or of
creating any liability to the PBGC under Section 4069 of ERISA or any other
provision of ERISA. Neither any plan (within the meaning of Section 4975(e)(1)
of the Code) nor employee benefit plan (within the meaning of Section 3(3) of
ERISA) nor any trust created thereunder, nor any trustee or administrator
thereof, has engaged in a prohibited transaction (within the meaning of Section
4975 of the Code or

                                     - 12 -
<PAGE>

Section 406 of ERISA) that could subject the Company or any Subsidiary to a
material tax or penalty on prohibited transactions imposed under said Section
4975 or Section 502(i) of ERISA.

         Except with respect to the Company's employee benefit plans, the
Company is not a party in interest with respect to any employee benefit plan (as
defined in ERISA). The execution and delivery of this Agreement and the other
Transaction Documents and the issuance and sale of the Securities hereunder will
not involve any prohibited transaction described in Section 406(a) of ERISA or
Section 4975(c)(1)(A), (B), (C) or (D) of the Code or any prohibited transaction
described in Section 406(b) of ERISA or Section 4975(c)(1)(E) or (F) of the Code
to which the Company or any of its Subsidiaries directly or indirectly, would be
a party.

         ss.2.23. No Brokers. Except as to Commonwealth Associates, no broker,
lender, agent or similar intermediary has acted for or on behalf of the Company
or is entitled to any broker's, finder's or similar fee or other commission in
connection with the transactions contemplated by this Agreement or the
Transaction Documents based on any agreement, arrangement or understanding with
the Company or any action taken by the Company. No transfers or payments made to
any party pursuant to this Agreement are being made as compensation for any
services performed by any person, and the Company shall not assert on any tax
return or informational filing with any taxing authority, or in any
administrative or judicial proceeding with respect to any such return or filing,
that any such transfers or payments constituted compensation for any services
performed by any person.

         ss.3. REPRESENTATIONS OF THE SUBSCRIBERS. Each Subscriber, severally
and not jointly, represents to the Company as follows:

         ss.3.1. Investment Purpose. Such Subscriber (i) is acquiring the Notes
and the Warrants and (ii) upon exercise of the Warrants and conversion of the
Notes, will acquire the Warrant Shares and Conversion Shares, as the case may
be, then issuable, for its own account for investment only and not with a view
towards, or for resale in connection with, the public sale or distribution
thereof, except pursuant to sales registered or exempted under the 1933 Act;
provided, however, that by making the representations herein, such Subscriber
does not agree to hold any of the Securities, Warrant Shares, Conversion Shares
or C Preferred Shares for any minimum or other specific term and reserves the
right to dispose of the Securities, Warrant Shares, Conversion Shares, and C
Preferred Shares at any time in accordance with or pursuant to a registration
statement or an applicable exemption under the 1933 Act and otherwise in
compliance with applicable federal and state securities laws.

         ss.3.2. Accredited Investor Status. Such Subscriber is an "accredited
investor" as that term is defined in Rule 501(a) of Regulation D.

                                     - 13 -
<PAGE>

         ss.3.3. Reliance on Exemptions. Such Subscriber understands that the
Securities, and C Preferred Shares issuable upon conversion of the Notes, are
being offered and sold to it in reliance on specific exemptions from the
registration requirements of United States federal and state securities laws and
that the Company is relying in part upon the truth and accuracy of, and such
Subscriber's compliance with, the representations, warranties, agreements,
acknowledgments and understandings of such Subscriber set forth herein in order
to determine the availability of such exemptions and the eligibility of such
Subscriber to acquire such Securities, or C Preferred Shares, as the case may
be.

         ss.3.4. No Governmental Review. Such Subscriber understands that no
United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the
Securities, the Conversion Shares, the Warrant Shares and the C Preferred Shares
or the fairness or suitability of the investment in the Securities, the
Conversion Shares, the Warrant Shares or the C Preferred Shares nor have such
authorities passed upon or endorsed the merits of the offering of the
Securities, the Conversion Shares, the Warrant Shares and the C Preferred
Shares.

         ss.3.5. Transfer or Resales. Such Subscriber understands that except as
provided in Annex A hereto: (i) the Securities, the Conversion Shares, the
Warrant Shares and the C Preferred Shares have not been and are not being
registered under the 1933 Act or any state securities laws, and may not be
offered for sale, sold, assigned or transferred unless (A) subsequently
registered thereunder, (B) such Subscriber shall have delivered to the Company
an opinion of counsel, in a form reasonably satisfactory to the Company, to the
effect that such Securities, Conversion Shares, Warrant Shares or C Preferred
Shares, as the case may be, to be sold, assigned or transferred may be sold,
assigned or transferred pursuant to an exemption from such registration, or (C)
such Subscriber provides the Company with reasonable assurance that such
Securities, Conversion Shares, Warrant Shares and C Preferred Shares can be
sold, assigned or transferred pursuant to Rule 144 promulgated under the 1933
Act (or a successor rule thereto) ("Rule 144"); (ii) any sale of the Securities,
the Conversion Shares, the Warrant Shares and the C Preferred Shares made in
reliance on Rule 144 may be made only in accordance with the terms of Rule 144
and further, if Rule 144 is not applicable, any resale of the Securities, the
Conversion Shares, the Warrant Shares and the C Preferred Shares under
circumstances in which the seller (or the person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the 1933 Act) may
require compliance with some other exemption under the 1933 Act or the rules and
regulations of the SEC thereunder; and (iii) neither the Company nor any other
person is under any obligation to register such Securities, Conversion Shares,
Warrant Shares and C Preferred Shares under the 1933 Act or any state securities
laws or to comply with the terms and conditions of any exemption thereunder.
Notwithstanding the foregoing, the Securities, the Conversion Shares, the
Warrant Shares and the C Preferred Shares may be pledged in connection with a
bona fide margin account or other loan secured by the Securities, the Conversion
Shares, the Warrant Shares or the C Preferred Shares, as the case may be.

                                     - 14 -
<PAGE>

         ss.3.6. Legends. Such Subscriber understands that the certificates or
other instruments representing the Note, the Warrants, the C Preferred Shares,
the Warrant Shares and the Conversion Shares, and until such time as the sale of
the Warrant Shares and the Conversion Shares have been registered under the 1933
Act as contemplated by Annex A hereto, the stock certificates representing the
Warrant Shares or the Conversion Shares, except as set forth below, shall bear a
restrictive legend in substantially the following form (and a stop-transfer
order may be placed against transfer of such stock certificates):

                  THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
         REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"),
         AND SUCH SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS SO
         REGISTERED OR AN EXEMPTION FROM REGISTRATION UNDER SAID ACT IS
         AVAILABLE.

The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of the Securities, the Conversion
Shares or the Warrants Shares, as the case may be upon which it is stamped, if
(i) such Securities, Conversion Shares or Warrant Shares, as the case may be are
registered for sale under the 1933 Act in which case the Company may include a
legend that such Securities, Conversion Shares or Warrant Shares, as the case
may be, have been registered under the 1933 Act and are subject to the
prospectus delivery requirements under the 1933 Act, (ii) in connection with a
sale transaction, the Company an opinion of counsel, in a form reasonably
satisfactory to the Company, to the effect that a public sale, assignment or
transfer of such Securities, Conversion Shares or Warrant Shares, as the case
may be may be made without registration under the 1933 Act, or (iii) such holder
provides the Company with reasonable assurances that such Securities, Conversion
Shares or Warrant Shares, as the case may be can be sold pursuant to Rule
144(k). Such Subscriber acknowledges, covenants and agrees to sell Securities
represented by a certificate(s) from which the legend has been removed, only
pursuant to (i) a registration statement effective under the 1933 Act, or (ii)
advice of counsel that such sale is exempt from the registration requirements of
Section 5 of the 1933 Act.

         ss.3.7. Authorization; Enforcement. This Agreement has been duly and
validly authorized, executed and delivered on behalf of such Subscriber and is a
valid and binding agreement of such Subscriber enforceable against such
Subscriber in accordance with their terms, subject as to enforceability to
general principles of equity and to applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other similar laws relating to, or
affecting generally, the enforcement of applicable creditors' rights and
remedies.

         ss.3.8. Residency. Such Subscriber is a resident of that jurisdiction
specified on Schedule I hereto.

                                     - 15 -
<PAGE>

         ss.3.9. Noteholders, Warrantholders and C Preferred Shareholders
Committees. Such Subscriber acknowledges and agrees that Commonwealth Associates
and each of the respective committees of holders of Notes, Warrants and C
Preferred Shares to be designated by Commonwealth Associates whose members hold
in the aggregate not less than (i) 20% of the principal amount of the
outstanding Notes (the "Noteholders Committee"), (ii) 20% of the Warrants (the
"Warrantholders Committee"), and (iii) in the event of conversion of the Notes
into the C Preferred Shares, 20% of the principal amount of the outstanding C
Preferred Shares (the "Preferred Shareholders Committee", and collectively with
the Noteholders Committee and Warrantholders Committee, the "Committees") may
consent, subject to the provision of Section 14 hereto, to any amendments,
modifications or waivers with respect to this Agreement and the respective
Transaction Documents (including, but not limited to the Notes, Warrants and C
Preferred Shares), and bind such Subscriber to any such amendment, modification
or waiver; provided, however, that no such amendment, modification or waiver
which would decrease the number of shares of Warrant Shares or Conversion Shares
issuable upon the exercise or conversion of the Securities or the C Preferred
Shares, or increase the Conversion Price therefor, other than as a result of the
waiver or modification of any anti-dilution provisions, may be made without the
approval of the holders of at least 50% of the outstanding the Notes, the
Warrants or the Series C Preferred Stock, as the case may be. Such Subscriber
acknowledges that neither Commonwealth Associates or any of its directors,
officers, employees or agents nor the Committees or any of its members will be
liable to such Subscriber for any action taken or omitted to be taken by it in
connection therewith, except for willful misconduct or gross negligence. Such
Subscriber acknowledges that one or more members of the Committees may be
affiliated with Commonwealth Associates. In connection with the foregoing, the
Company is entitled to rely upon and assume the accuracy and completeness of the
certificate supplied by any such Committee and the Company shall not be liable
to the Purchasers for any action taken or omitted to be taken in accordance with
and reliance on such certificate.

         ss.3.10. Lock-Up. Effective as of the date hereof, each of the
Subscribers agrees to the terms and provisions of Annex B hereto, which terms
and provisions are incorporated herein by reference in their entirety and made
part hereof and set forth the rights and obligations of the several Subscribers
in respect of certain limitations on sale or transfer of the Conversion Shares
and the Warrant Shares.

         ss.3.11. Reliance on Documents. Such Subscriber has been furnished with
and has carefully read the Memorandum. In evaluating the suitability of an
investment in the Company, the such Subscriber has not relied upon any
representations or other information (whether oral or written) from the Company
or any of its agents other than as set forth in the Memorandum and the
Transaction Documents.

         ss.3.12. Investment Risk. Such Subscriber recognizes that investment in
the Company involves substantial risks and represents that he has taken full
cognizance of and understands all of

                                     - 16 -
<PAGE>

the risk factors related to the purchase of Units, including, but not limited
to, those set forth under the caption "Risk Factors" in the Memorandum.

         ss.4. CONDITIONS OF CLOSING. The obligations of each Subscriber
hereunder required to be performed at the Closing shall be subject, at their
respective elections, to the satisfaction or waiver (which waiver, if so
requested by the Company, shall be made in writing), at or prior to the Closing,
of the following conditions:

         ss.4.1. Representations and Warranties. The representations and
warranties of the Company contained in this Agreement shall have been true and
correct when made and, in addition, shall be repeated and true and correct on
and as of the Closing Date with the same force and effect as though made on and
as of the Closing Date.

         ss.4.2. Performance of Obligations, Etc. The Company shall have
performed in all material respects all obligations and agreements, and complied
in all material respects with all covenants, contained in this Agreement, to be
performed and complied with by it at or prior to the Closing Date.

         ss.4.3. Transaction Documents. Each Transaction Document, and all other
documents, instruments, agreements or arrangements related thereto, shall be in
full force and effect and in form and substance reasonably satisfactory to each
of the Subscribers, and no material term or condition in any Transaction
Document shall have been amended, waived or otherwise modified in any respect
without the written consent of each of the Subscribers, neither of the
Subscribers shall have given notice to the Company that, in such Subscriber's
reasonable judgment, any applicable conditions to Closing have not been
fulfilled or waived by any such Subscriber, and no party to any Transaction
Document shall be in breach of or in default thereunder and no event or
circumstance shall have occurred which, with or without the giving of notice or
lapse of time, or both, would be reasonably likely to result in a right of
termination in respect thereof.

         ss.4.4. No Default, Etc. There shall be no (i) existing material
default by the Company or any party thereto or (ii) any event which, after
notice or lapse of time or both, would constitute a material default or result
in a right to accelerate, suspend or terminate or result in a loss of rights of
the Company, under any of the Company's agreements, including, without
limitation, the Redemption Agreement.

         ss.4.5. Compliance with Laws. The operations and activities of the
Company shall have complied in all respects with all applicable federal, state,
local and foreign laws, statutes, rules, regulations, judicial and
administrative decisions and consents, judgments, orders, awards, writs and
decrees of any court, governmental or regulatory body, administrative agency or
arbitrator, including, without limitation, health and safety statutes and
regulations and all environmental laws.

                                     - 17 -
<PAGE>

         ss.4.6. No Litigation, Etc. There shall be no litigation, proceeding or
other action seeking an injunction or other restraining order, damages or other
relief from a court or governmental authority pending or threatened which, in
the reasonable judgment of any of the Subscribers, could be reasonably likely to
have a Material Adverse Effect and there shall be no litigation, proceeding or
other action pending or threatened against any of the Subscribers which is
reasonably likely to have a Material Adverse Effect.

         ss.4.7. Proceedings Satisfactory. All corporate and other proceedings
taken or to be taken by the Company in connection with this Agreement shall be
in form and substance reasonably satisfactory to each of the Subscribers as
being consistent with satisfaction of the foregoing conditions.

         ss.4.8. Approvals and Consents. All governmental and regulatory
approvals and clearances and all third party consents necessary for the
consummation of the transactions contemplated hereby shall have been obtained
and shall be in full force and effect, and each Subscriber shall be reasonably
satisfied that this Agreement does not and will not contravene any applicable
provision of any law, statute, regulation, order, writ, injunction or decree of
any court or governmental instrumentality, except to the extent any
contravention or contraventions, individually or in the aggregate, could not
reasonably be expected to have a Material Adverse Effect.

         ss.4.9. Officer's Certificate. The Company shall have delivered to the
Subscribers a certificate executed by it or on its behalf by a duly authorized
executive officer, dated the Closing Date, to the effect that the Company has
fulfilled the conditions applicable to it specified in Sections 4.1 - 4.8 above
and this Section 4.9.

         ss.4.10. Opinion of Counsel for the Company. Holland & Knight, LLP,
counsel to the Company, shall have delivered to the Subscribers its opinions,
dated the Closing Date, addressed to the Subscribers as to the matters set forth
in Exhibit F hereto.

         ss.4.11. Securities. Each of the Subscribers shall have subscribed for
and purchased and received delivery of the Securities as set forth herein.

         ss.4.12. Other Matters. Each Subscriber shall have received such other
certificates, instruments and documents in furtherance of the transactions
contemplated by this Agreement as they may reasonably request.

         ss.4A. CONDITIONS OF CLOSING. The obligations of the Company hereunder
required to be performed at the Closing shall be subject, at its election, to
the satisfaction or waiver (which waiver, if so requested by any Subscriber,
shall be made in writing), at or prior to the Closing, of the following
conditions:

                                     - 18 -
<PAGE>

         ss.4A.1. Representations and Warranties. The representations and
warranties of each Subscriber contained in this Agreement shall have been true
and correct when made and, in addition, shall be repeated and true and correct
on and as of the Closing Date with the same force and effect as though made on
and as of the Closing Date.

         ss.4A.2. Performance of Obligations, Etc. Each Subscriber whose
subscription is accepted by the Company shall have performed in all material
respects all obligations and agreements, and complied in all material respects
with all covenants, contained in this Agreement, to be performed and complied
with by it at or prior to the Closing Date.

         ss.4A.3. Transaction Documents. Each Transaction Document, and all
other documents, instruments, agreements or arrangements related thereto, shall
be in full force and effect and in form and substance reasonably satisfactory to
the Company, and no material term or condition in any Transaction Document shall
have been amended, waived or otherwise modified in any respect without the
written consent of the Company, the Company shall not have given notice to the
Subscribers that, in its reasonable judgment, any such applicable conditions to
Closing have not been fulfilled or waived by the Company, and no party to any
Transaction Document shall be in breach of or in default thereunder and no event
or circumstance shall have occurred which, with or without the giving of notice
or lapse of time, or both, would be reasonably likely to result in a right of
termination in respect thereof.

         ss.4A.4. No Litigation, Etc. There shall be no litigation, proceeding
or other action seeking an injunction or other restraining order, damages or
other relief from a court or governmental authority pending or threatened which,
in the reasonable judgment of the Company, could be reasonably likely to have a
Material Adverse Effect and there shall be no litigation, proceeding or other
action pending or threatened against the Company which is reasonably likely to
have a Material Adverse Effect.

         ss.4A.5. Approvals and Consents. All governmental and regulatory
approvals and clearances and all third party consents necessary for the
consummation of the transactions contemplated hereby shall have been obtained
and shall be in full force and effect, and each Subscriber shall be reasonably
satisfied that this Agreement does not and will not contravene any applicable
provision of any law, statute, regulation, order, writ, injunction or decree of
any court or governmental instrumentality, except to the extent any
contravention or contraventions, individually or in the aggregate, could not
reasonably be expected to have a Material Adverse Effect.

         ss.5. PAYMENT OF THE NOTES.

         ss.5.1. Principal and Interest Payments. The Company shall pay, and
there shall become due and payable, the entire principal amount of the Notes on
January 1, 2001 (or such earlier

                                     - 19 -
<PAGE>

date as provided in the Notes or herein) (the "Maturity Date"). Interest in the
Notes shall be computed and paid in the manner provided in the Notes.

         ss.5.2. Mandatory Reserve for Repayments.

                  (1) Notwithstanding anything to the contrary provided herein
or elsewhere, in the event that prior to the Maturity Date, the Company receives
in the aggregate from the sale of its debt and/or equity securities gross
proceeds, such sale being unrelated to the financing contemplated by this
Agreement, in the amount greater than or equal to the aggregate principal amount
of the Notes issued and sold, the Company shall set aside and reserve from the
net proceeds thereof an amount sufficient to repay at the Maturity Date the
aggregate principal amount outstanding under the Notes, and all accrued interest
thereon, and the Company shall apply such proceeds for such purposes at the
Maturity Date.

                  (2) The Company shall provide in any applicable financing
document that the Company uses in connection with any future financing unrelated
to the financing contemplated by this Agreement that the required amount of
funds raised will be used to repay the principal amount and all accrued and
unpaid interest thereon under the Notes at the Maturity Date and the Company
shall provide to the holders of Notes no later than five (5) business days prior
to the date of funding of any such financing the date such financing is expected
to close, the amount of financing to be received, the place and time of such
closing, and all other such applicable information the holders of Notes shall
subsequently request.

         ss.5.3. No Prepayment. The Notes may not be prepaid.

         ss.5.4. Surrender of Notes; Notation Thereon. Subject to the provisions
of ss.12, the Company may, as a condition of payment of all or any part of the
principal of, and interest on, any Note, require the holder to present such Note
for notation of such payment and, if such Note be paid in full, require the
surrender thereof.

         ss.5.5. Purchase of Notes. The Company will not, and will not permit
any Affiliate to, acquire directly or indirectly by purchase or prepayment or
otherwise any of the outstanding Notes except by way of payment in accordance
with the provisions of the Notes and of this Agreement.

         ss.5A. CONVERSION.. The principal of, and accrued interest on, the
Notes shall be convertible into shares of Common Stock and/or Series C Preferred
Stock as set forth below. In addition, consistent with the provisions set forth
below, the Conversion Price in effect at any time and the number and kind of
securities issuable upon conversion of the Notes into Common Stock shall be
subject to the anti-dilution adjustment provisions set forth in Section 4 of the
Series C Designation, treating the aggregate principal of, and accrued interest,
on such Notes as if was Liquidation Preference, as defined in the Series C
Designation, for purposes of the anti-dilution adjustments only.

                                     - 20 -
<PAGE>

The conversion of the C Preferred Shares shall be as set forth in the last
sentence of Section 5.A.2 below.

         ss.5A.1. Optional Conversion. As provided in Section 1.5 above, at any
time prior to a mandatory conversion pursuant to Section 5A.2, each holder of
the Notes shall have the right at such holder's option, at any time from time to
time, but no earlier than the first to occur of (a) the Company obtaining
shareholder approval of the issuance of the Securities or (b) September 4, 2000,
to convert all or any portion of the principal of, and accrued interest on, such
holder's Notes into fully paid and nonassessable shares of Common Stock at the
Conversion Price and in accordance with the conversion procedures set forth
herein.

         ss.5A.2. Mandatory Conversion. Notwithstanding anything to the contrary
provided herein or elsewhere, in the event that prior to the Maturity Date, the
Company effects the full redemption of the Series B Preferred Stock in
accordance with the terms of the Redemption Agreement, then the principal amount
of the Notes and interest accrued thereon shall automatically be converted,
without any further act of the Company, into fully paid and nonassessable shares
of C Preferred Shares in accordance with the conversion procedures set forth
herein and in the Series C Designation, at the rate of one share of C Preferred
Shares, for every $100 of the principal amount of the Notes plus interest
accrued thereon. For purposes of the mandatory conversion described in this
Section 5A.2, the Conversion Price shall be at the rate specified in the
previous sentence. The number and kind of securities issuable upon conversion of
the C Preferred Shares shall be subject to the anti-dilution adjustment
provisions set forth in Section 4 of the Series C Designation which adjustments
shall become effective on and as of the Closing Date and not the issuance date
of any C Preferred Shares.

         ss.5A.3. Mechanics of Conversion. Upon conversion, the holder of the
Notes will surrender the Notes, at the office of the Company or of any transfer
agent for the Notes, and such holder will give written notice to the Company
stating the name or names in which such holder wishes the certificate or
certificates for shares of Common Stock or C Preferred Shares, as applicable, to
be issued. The Company, as soon as practicable thereafter, will issue and
deliver at such office to such holder of the Notes or to such holder's nominee
or nominees, a certificate or certificates for the number of shares of Common
Stock or C Preferred Shares, as applicable, to which such holder will be
entitled as aforesaid. Any conversion will be deemed to have been made
immediately prior to the close of business on the date of the event of
conversion, in the event of automatic conversion hereunder, or, in the event of
voluntary conversion, immediately prior to the close of business on the date
when the Company receives a holder's Notes and any other documents or
instruments required hereunder or by applicable law, and the person or persons
entitled to receive the shares of Common Stock or C Preferred Shares, as
applicable, issuable upon conversion will be treated for all purposes as the
record holder or holders of such shares of Common Stock or C Preferred Shares,
as the case may be, on such date and any such date is referred to herein as the
"Conversion Date."

                                     - 21 -
<PAGE>

         ss.5A.4. Cash Payments. No fractional shares (or scrip representing
fractional shares) of Common Stock and C Preferred Shares, as the case may be,
shall be issued upon conversion of the Notes. In the event that the conversion
of the Notes would result in the issuance of a fractional share of Common Stock
or C Preferred Shares, as the case may be, the Company shall pay a cash
adjustment in lieu of such fractional share to the holder of the Notes based
upon the current market value thereof (as determined in accordance with Section
9 of the Series C Designation and Section 1.5 of the Warrants.

         ss.5A.5. Stamp Taxes, Etc. The Company shall pay all documentary, stamp
or other transactional taxes attributable to the issuance or delivery of shares
of Common Stock or C Preferred Shares, as applicable, upon conversion of the
Notes; provided, however, that the Company shall not be required to pay any
taxes which may be payable in respect of any transfer involved in the issuance
or delivery of any certificate for such shares in a name other than that of the
holder of the Notes, and the Company shall not be required to issue or deliver
any such certificate unless and until the person requesting the issuance thereof
shall have paid to the Company the amount of such tax or shall have established
to the Company's satisfaction that such tax has been paid.

         ss.6. FINANCIAL STATEMENTS AND INFORMATION. The Company will furnish to
each Subscriber, so long as it shall be obligated to subscribe for and purchase
or shall hold any of the Notes or the C Preferred Shares, and each other
institutional holder of any of the Notes or the C Preferred Shares, in
duplicate:

                  (1) as soon as available and in any event within 45 days after
         the end of the first, second and third quarterly accounting periods in
         each fiscal year of the Company, copies of a consolidated balance sheet
         of the Company and its Subsidiaries as of the end of such accounting
         period and of the related consolidated statements of income,
         shareholders' equity and cash flows of the Company and its Subsidiaries
         for the portion of the fiscal year ended with the last day of such
         quarterly accounting period, all in reasonable detail and stating in
         comparative form the respective consolidated figures for the
         corresponding date and period in the previous fiscal year and all
         certified by the principal financial officer of the Company to present
         fairly the information contained therein, subject to year-end and audit
         adjustments (it being understood that such delivery obligation shall be
         deemed satisfied by the Company's filing of the Quarterly Report on
         Form 10-Q in respect of such period with the SEC pursuant to Section
         13(a) of the Exchange Act so long as such Report otherwise meets the
         requirements of this Clause (A)); and

                  (2) as soon as available and in any event within 90 days after
         the end of each fiscal year of the Company, copies of a consolidated
         balance sheet of the Company and its Subsidiaries as of the end of such
         fiscal year and of the related

                                     - 22 -
<PAGE>

         consolidated statements of income, shareholders' and cash flows of the
         Company and its Subsidiaries for such fiscal year, all in reasonable
         detail and stating in comparative form the respective consolidated
         figures as of the end of and for the previous fiscal year and all
         accompanied by a report thereon of PricewaterhouseCoopers LLP, or other
         independent public accountants of recognized national standing selected
         by the Company (it being understood such delivery obligation shall be
         deemed satisfied by the Company's filing of the Annual Report on Form
         10-K in respect of such fiscal year with the SEC pursuant to Section
         13(a) of the Securities Act so long as such Report otherwise meets the
         requirements of this Clause (B));

                  (3) concurrently with the financial statements for each
         quarterly accounting period and for each fiscal year of the Company,
         furnished pursuant to Subsections (A) and (B) of this Section, a
         certificate of the President, a Vice President or the Treasurer of the
         Company stating that, based upon such examination or investigation and
         review of this Agreement as in the opinion of the signer is necessary
         to enable the signer to express an informed opinion with respect
         thereto, neither the Company nor any of its Subsidiaries is or has
         during such period been in default in the performance or observance of
         any of the terms, covenants or conditions hereof, or, if the Company or
         any of its Subsidiaries shall be or shall have been in default,
         specifying all such defaults, and the nature and period of existence
         thereof, and what action the Company has taken, is taking or proposes
         to take with respect thereto;

                  (4) promptly after the receipt thereof by the Company and in
         any event within 15 days after such receipt, copies of any reports as
         to material inadequacies in accounting controls (including reports as
         to the absence of any such inadequacies) submitted to the Company by
         independent accountants in connection with any audit of the Company or
         of any Subsidiary made by such accountants;

                  (5) promptly after the same are available and in any event
         within 15 days thereof, copies of all such proxy statements, financial
         statements and reports as the Company shall send or make available
         generally to any of its security holders or as any Subsidiary shall
         send or make available generally to any of its security holders other
         than the Company or another Subsidiary, and copies of all regular and
         periodic reports and of all registration statements (other than on Form
         S-8 or a similar form) which the Company or any Subsidiary may file
         with the SEC or with any securities exchange (it being understood that
         such delivery obligation shall be deemed satisfied by the Company's
         filing of the applicable report or

                                     - 23 -
<PAGE>

         statement with the SEC pursuant to the Exchange Act so long as such
         report or statement otherwise meets the requirements of this Clause
         (E));

                  (6) promptly after a responsible officer shall become aware of
         the existence of a Default or Event of Default, a certificate of the
         President, a Vice President or a senior financial officer of the
         Company specifying the nature and period of existence thereof and what
         action the Company or a Subsidiary, as the case may be, is taking or
         proposes to take with respect thereto; and

                  (7) such other information, including financial statements and
         computations, relating to the performance of the provisions of this
         Agreement and the affairs of the Company and any of its Subsidiaries as
         any of the Subscribers or any such holder may from time to time
         reasonably request (including without limitation the information the
         Company must deliver to any holder or to any prospective transferee of
         a Note in order to permit the sale or other transfer of such Note
         pursuant to Rule 144A of the SEC or any similar rule then in effect).

         The Company will keep at its principal executive office, a true copy of
this Agreement (as at the time in effect), and cause the same to be available
for inspection at said office during normal business hours by any holder of a
Note or any prospective subscriber of a Note designated by a holder thereof.

         ss.7. INSPECTION OF PROPERTIES AND BOOKS. So long as any of the
Subscribers shall be obligated to subscribe for and purchase, or any Subscriber
or any other institutional investor shall hold, Notes, such Subscriber or such
other holder (and their respective representatives and agents) shall have the
right, at any Subscriber's or such holder's expense, to visit and inspect any of
the properties of the Company and of its Subsidiaries, to examine the books of
account and records of the Company and of its Subsidiaries, to make or be
provided with copies and extracts therefrom, to discuss the affairs, finances
and accounts of the Company and of its Subsidiaries with, and to be advised as
to the same by, its and their officers, employees and independent public
accountants (and by this provision the Company authorizes said accountants to
discuss such affairs, finances and accounts, whether or not a representative of
the Company is present) all at such reasonable times and intervals and to such
reasonable extent as such Subscriber or such other holder may desire.

         ss.7.A. REGISTRATION RIGHTS. The Company and each of the Subscribers,
respectively, agree to the terms and provisions of Annex A hereto, which terms
and provisions are incorporated herein by reference in their entirety and made
part hereof and set forth the respective rights and obligations of the Company
and the several Subscribers in respect of registration rights and certain other
matters relating to the shares of Common Stock underlying the Notes, the
Warrants and the C Preferred Shares.

                                     - 24 -
<PAGE>

         ss.8. AFFIRMATIVE COVENANTS. The Company covenants and agrees with
respect to the Company and each of the Subsidiaries that on and after the date
hereof, so long as any Notes shall be outstanding or at least 10% of the C
Preferred Shares are issued and outstanding, it will perform the obligations set
forth in this Section 8:

         ss.8.1. Payment of Principal, Interest and Premium; to Keep Books;
Reserves. The Company will duly and punctually pay the principal of and interest
and premium, if any, on the Notes in accordance with the terms of the Notes and
this Agreement. The Company will, and will cause each of its Subsidiaries to,
keep proper books of record and account and set aside appropriate reserves, all
in accordance with GAAP.

         ss.8.2. Corporate Existence; Payment of Taxes; Conduct of Business;
Maintenance of Properties; Compliance with Laws; Insurance; Books and Records.
The Company will, and will cause each of its Subsidiaries to,

                  (1) do or cause to be done all things necessary to preserve
         and keep in full force and effect its corporate existence,
         organization, rights (charter and statutory) and franchises;

                  (2) promptly pay and discharge all taxes, assessments and
         governmental charges or levies imposed upon it or upon its income or
         profits or upon any of its property, real, personal or mixed, or upon
         any part thereof, before the same shall become delinquent, as well as
         all claims for labor, materials and supplies which, if unpaid, might
         become a Lien (as hereinafter defined) or charge upon such property or
         any part thereof; provided, however, that the Company shall not be
         required to pay and discharge any such tax, assessment, charge, levy or
         claim so long as the validity thereof shall be contested in good faith
         by appropriate proceedings and the Company shall set aside on its books
         adequate reserves in accordance with GAAP with respect to any such tax
         assessments, charge, levy or claim so contested;

                  (3) use its best efforts to conduct its business in a manner
         consistent with past practices, do or to be done all things necessary
         to preserve relationship with its vendors, customers, distributors,
         sales representatives and others having business relationship with the
         Company or any of its Subsidiaries, and inform and consult with the
         Subscriber on any key decisions involving any capital expenditure in
         excess of $250,000;

                  (4) maintain, preserve, protect and keep its business and
         properties used and useful in the conduct of its business, in good
         repair, working order and condition in accordance with all applicable
         laws, permits and warranties, and from

                                     - 25 -
<PAGE>

         time to time make all needful and proper repairs, renewals,
         replacements and improvements thereto as shall be reasonably required
         in the conduct of its business, and protect and maintain its patents,
         copyrights, trademarks and trade secrets and all registrations and
         applications for registration thereof;

                  (5) use its best efforts to comply with all applicable
         statutes, regulations and orders of, and all applicable restrictions
         imposed by, any governmental agency, in respect of the conduct of its
         business and the ownership of its properties (including without
         limitation applicable statutes, regulations and orders relating to
         equal employment opportunities or environmental standards or controls),
         except such as are being contested in good faith by appropriate
         proceedings;

                  (6) to the extent necessary for the operation of its business,
         keep adequately insured by financially sound reputable insurers, all
         properties insured by similar corporations and carry such other
         insurance as is usually carried by similar corporations and the Company
         will, and will cause each Subsidiary to, maintain with financially
         sound insurers public liability insurance against claims for personal
         injury, death or property damage suffered by others upon or in or about
         any premises occupied by it or occurring as a result of its ownership,
         maintenance or operations of any automobiles, trucks or other vehicles,
         aircraft or other facilities or as a result of the use of products
         manufactured, constructed or sold by it or services rendered by it, in
         such amounts (and with such deductibles) as such insurance is usually
         carried by companies engaged in a similar business and as is in
         accordance with good business practice; and

                  (7) at all times keep true and correct books, records and
         accounts reflecting all of its business affairs and transactions in
         accordance with GAAP, and such books and records shall be open at
         reasonable times and upon reasonable notice to the inspection of each
         of the Subscribers or their respective agents.

         ss.8.3. Notice of Certain Events. The Company will, and will cause each
of its Subsidiaries to, give prompt written notice (with description in
reasonable detail) to each Subscriber of:

                  (1) the occurrence of any Event of Default (as defined in
         ss.11) or any event or condition which, with the giving of notice or
         the lapse of time, would constitute an Event of Default, specifying the
         nature and extent thereof and the action (if any) which is proposed to
         be taken with respect thereto;

                                     - 26 -
<PAGE>

                  (2) the delivery of any notice effecting the acceleration of
         any indebtedness in excess of $100,000;

                  (3) the issuance by any court or governmental agency or
         authority of any injunction, order, decision or other restraint
         prohibiting, or having the effect of prohibiting, the making of or
         invalidating, or having the effect of invalidating, any provision of
         this Agreement, of the initiation of any litigation or similar
         proceedings seeking any such injunction, order, decision, or other
         restraint;

                  (4) the filing or commencement of any action, suit or
         proceeding against the Company, whether at law or in equity or by or
         before any court of any Federal, state, municipal or other governmental
         agency or authority, which is brought by or on behalf of any
         governmental agency or authority, or in which injunctive or other
         equitable relief is sought and such relief, if obtained, would
         materially impair the right or ability of the Company to perform it
         obligations under this Agreement;

                  (5) the commencement or threat against the Company or any of
         the Subsidiaries of any claim, litigation, proceeding or tax audit not
         covered by insurance when the amount claimed is in any individual
         claim, litigation, proceeding or tax audit in excess of $100,000 or, in
         the aggregate, $250,000; and

                  (6) of any material development materially affecting business,
         properties, liabilities, obligations, financial condition, operations,
         results of operations, or future prospects of the Company or any of its
         subsidiaries.

         ss.9. NEGATIVE COVENANTS. The Company covenants and agrees with respect
to the Company and each of the Subsidiaries that on and after the date hereof,
so long as any Note shall be outstanding or at least 10% of the C Preferred
Shares are issued and outstanding, it will perform the obligations set forth in
this Section 9:

         ss.9.1. Business in the Ordinary Course. The Company will, and will
cause each of its Subsidiaries to, (i) refrain from engaging in transactions
other than in the ordinary course of business consistent with past practice
(except as otherwise may be consistent with a business plan approved by a
majority of the independent members of the Board of Directors); (ii) operate its
respective businesses in accordance and in compliance with all applicable laws,
ordinances, rules or regulations or orders, including, without limitation
environmental laws, and all permits, authorizations, consents and approvals;
(iii) maintain all permits and licenses in effect and, if necessary, make all
appropriate filings for the renewal of any permits or licenses; (iv) refrain
from entering into any transaction involving capital expenditures or commitments
therefor (including any borrowings in connection with such transaction) of more
than $100,000, individually, or $250,000

                                     - 27 -
<PAGE>

in the aggregate, or the disposal of any properties or assets (other than
inventory in the ordinary course) with a value of more than $100,000,
individually, or $250,000, in the aggregate.

         ss.9.2. Liquidation, Dissolution. The Company will not, and will not
permit any of its Subsidiaries to, liquidate or dissolve, consolidate with, or
merge into or with, any other corporation or other entity or acquire any stock
or assets of any person or entity, except that any wholly-owned subsidiary may
merge with another wholly-owned subsidiary or with the Company (so long as the
Company is the surviving corporation and no Event of Default (as defined in
ss.11) shall occur as a result thereof).

         ss.9.3. Capitalization, Options and Payments. Except as contemplated by
this Agreement or permitted by written consent of the Committee, the Company
will not, and will not permit any of its Subsidiaries to, (i) make any changes
in the Articles of Incorporation or By-laws of the Company or any of the
Subsidiaries; (ii) issue or reclassify or alter any shares of its outstanding or
unissued capital stock or other securities; (iii) grant greater than 250,000
options, warrants or other rights of any kind to purchase any of its securities,
or agree to issue any shares of its capital stock or any other securities; (iv)
make any payments to officers of the Company or any Subsidiary, except for
payments of compensation at current levels; or (v) effect any recapitalization,
reclassification, stock split or like change in its capitalization.

         ss.9.4. Sales of Assets. The Company will not, and will not permit any
of its Subsidiaries with respect to their assets and properties, to sell,
transfer, lease or otherwise dispose of, or grant options, warrants or other
rights with respect to, all or a substantial part of its properties or assets
(whether now owned or hereafter acquired) to any person or entity, provided that
this Section 9.2 shall not restrict any disposition made in the ordinary course
of business and consisting of (a) capital goods which are obsolete or have no
remaining useful life or (b) finished goods inventories.

         ss.9.5. Real Property Acquisitions, Dispositions and Leases. The
Company will, and will cause each of its Subsidiaries to, refrain from acquiring
or agreeing to acquire real estate and from entering into or agreeing to enter
into leases of real estate or equipment, and from creating any modification,
amendment or termination of the leases for the leased real property, provided
that this Section 9.5 shall not restrict any such transaction if made in the
ordinary course of business.

         ss.9.6. Redemptions. The Company will not redeem, repurchase or
otherwise acquire for consideration any outstanding equity and/or debt
securities of the Company or its Subsidiaries (or securities convertible into or
exchangeable for equity and/or debt securities of such entity), except for as
contemplated by the Redemption Agreement.

         ss.9.7. Indebtedness. Other than (i) the Notes subject to this
Agreement, (ii) indebtedness of the Company existing on the date of this
Agreement and set forth on Schedule 2.9 (including, without limitation, any
renewal, extension, refunding, reconstructing, replacement or

                                     - 28 -
<PAGE>

refinancing thereof) and other indebtedness in unpaid principal amounts not
exceeding $50,000, (iii) other indebtedness and/or equity that by its terms is
expressly subordinate (in form and substance satisfactory to the Subscribers) to
the Notes, and (iv) indebtedness to trade creditors incurred in the ordinary
course of business (collectively, the "Permitted Indebtedness"), the Company
will hereafter not create, incur, assume or suffer to exist, contingently or
otherwise, any indebtedness. Neither the Company nor any of its Subsidiaries
will make any Loans or advances to, or assume, guarantee or otherwise become
liable for any indebtedness of any director, officer or employee of the Company
or any of its Subsidiaries other than in the ordinary course of business
consistent with past practice.

         ss.9.8. Negative Pledge. Other than with respect to the Permitted
Indebtedness, Company will not, and it will not permit its Subsidiaries to,
hereafter create, incur, assume or suffer to exist any mortgage, pledge,
hypothecation, assignment, security interest, encumbrance, lien (statutory or
other), preference, priority or other security agreement or preferential
arrangement of any kind or nature whatsoever (including any conditional sale or
other title retention agreement and any financing lease) (each, a "Lien") upon
any of its property, revenues or assets, whether now owned or hereafter
acquired, except:

                  (1) Liens granted to secure indebtedness incurred to finance
         the acquisition (whether by purchase or capitalized lease) of tangible
         assets, but only on the assets acquired with the proceeds of such
         indebtedness;

                  (2) Liens for taxes, assessments or other governmental charges
         or levies not at the time delinquent or thereafter payable without
         penalty or being contested in good faith by appropriate proceedings and
         for which adequate reserves in accordance with GAAP shall have been set
         aside on its books;

                  (3) Liens of carriers, warehousemen, mechanics, materialman
         and landlords incurred in the ordinary course of business for sums not
         overdue or being contested in good faith by appropriate proceedings and
         for which adequate reserves in accordance with GAAP shall have been set
         aside on its books;

                  (4) Liens (other than Liens arising under the Employee
         Retirement Income Security Act of 1974, as amended, or Section 412(n)
         of the Internal Revenue Code of 1986, as amended) incurred in the
         ordinary course of business in connection with workers' compensation,
         unemployment insurance or other forms of governmental insurance or
         benefits, or to secure performance of tenders, statutory obligations,
         leases and contracts (other than for borrowed money) entered into in
         the ordinary course of business or to secure obligations on surety or
         appeal bonds;

                  (5) judgment Liens in existence less than 30 days after the
         entry thereof or with respect to which execution has been stayed; and

                                     - 29 -
<PAGE>

                  (6) Liens in existence on the date hereof as stated under
         Section 2.9 and Schedule 2.9, including, without limitation, the lien
         in favor of Transamerica Business Credit Corporation pursuant to the
         Loan and Security Agreement dated July 20,1999 by and between the
         Company and Transamerica Business Credit Company.

         ss.9.9. Investments. The Company will not, and will not permit any of
its Subsidiaries to, purchase, own, invest in or otherwise acquire, directly or
indirectly, any stock or other securities or make or permit to exist any
investment or capital contribution or acquire any interest whatsoever in any
other person or entity or permit to exist any loans or advances for such
purposes except for investments in direct obligations of the United States of
America or any agency thereof, obligations guaranteed by the United States of
America and certificates of deposit or other obligations of any bank or trust
company organized under the laws of the United States or any state thereof and
having capital and surplus of at least $500,000,000.

         ss.9.10. Transactions with Affiliates. The Company will not, and will
not permit any of its Subsidiaries to, enter into any transaction, including,
without limitation, the purchase, sale, lease or exchange of property, real or
personal, the purchase or sale of any security, the borrowing or lending of any
money, or the rendering of any service, with any person or entity affiliated
with the Company or any of its Subsidiaries (including officers, directors and
shareholders owning three (3%) percent or more of the Company's outstanding
capital stock), except in the ordinary course of and pursuant to the reasonable
requirements of its business and upon fair and reasonable terms not less
favorable than would be obtained in a comparable arms-length transaction with
any other person or entity not affiliated with the Company and, where the
transaction is valued at in excess of $50,000, with the prior written consent of
each of the Subscribers.

         ss.9.11. Dividends. The Company will not, and will not permit any of
its Subsidiaries to, declare, pay, set aside or make any cash dividends or
distributions on its outstanding capital stock or any other securities, except
the Series B Preferred Stock and the Series C Preferred Stock.

         ss.9.12. Subsidiaries. The Company will not, and will not permit any of
its Subsidiaries to, create any subsidiaries.

         ss.9.13. Employee Matters. Except as permitted by written consent of
each of the Subscribers, the Company will not, and will not permit any of its
Subsidiaries to, make, amend or enter into any employment contract and to take
any action to amend or terminate any employee benefit plan or adopt any other
plan, program, arrangement or practice providing new benefits or compensation to
its employees unless such action is required by law.

                                     - 30 -
<PAGE>

         ss.9.14. Accounting, Credit Changes and Banking Arrangements. The
Company will not, and will not permit any of its Subsidiaries to, make any
change in its accounting procedures and practices or its credit criteria from
those in existence at December 31, 1999, except as required due to changes in
GAAP; provided that the Company will, and will cause each of its Subsidiaries
to, notify each Subscriber of any such changes required due to changes in GAAP.

         ss.9.15. Tax Elections. Except as permitted by written consent of each
of the Subscribers, the Company will not, and will not permit any of its
Subsidiaries to, make any tax election that would have a material adverse effect
on the Company or any of its Subsidiaries.

         ss.10. DEFINITIONS.

         ss.10.1. Certain Definitions. Except as otherwise specified or as the
context may otherwise require, the following terms shall have the respective
meanings set forth below whenever used in this Agreement:

         "Affiliate" of any specified person means any other person controlling
or controlled by or under common control with such specified person. For the
purposes of this definition, "control" when used with respect to any specified
person means the power to direct the management and policies of such person,
directly or indirectly, whether through the ownership of voting securities, by
contract or otherwise; and the terms "controlling" and "controlled" have
meanings correlative to the foregoing.

         "Business Day" means any day except a Saturday, a Sunday or a legal
holiday in The City of New York.

         "CERCLA" has the meaning specified in ss.2.21.

         "Closing Date" has the meaning specified in ss.1.2.

         "Code" means the Internal Revenue Code of 1986, as amended.

         "Default" means any default or other event which, with notice or the
lapse of time or both, would constitute an Event of Default.

         "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended, and the regulations issued thereunder.

         "ERISA Affiliate" means any corporation, trade or business that is,
along with the Company, a member of a controlled group of corporations or a
controlled group of trades or businesses, as described in section 414 of the
Code or section 4001 of ERISA; provided that, after

                                     - 31 -
<PAGE>

the distribution date of the common stock of the Company by Whitman, "ERISA
Affiliate" shall not include any Person which ceases to be (as a result of such
distribution), along with the Company, a member of a controlled group of
corporations or a controlled group of trades or businesses, as described in
section 414 of the Code or section 4001 of ERISA.

         "Event of Default" has the meaning specified in ss.11.1.

         "Hazardous Substance" means and includes (i) any asbestos, PCBs, or
dioxins, or insulation or other material composed of or containing asbestos, CBs
or dioxins, (ii) any petroleum product, and (iii) any hazardous, toxic or
dangerous waste, substance, or material defined as such in (or for purposes of)
CERCLA, any so-called "Superfund" or "Superlien" law, or any other applicable
federal, state, local, or other statute, law, ordinance, code, rule, regulation,
order, or decree regulating to, or imposing liability or, standards of conduct
concerning, any hazardous toxic, or dangerous waste, substance, or material, as
now or at any time hereafter in effect.

         "Multiemployer Plan" has the meaning assigned to such term in section
3(37) of ERISA.

         "Person" or "person" includes an individual, a corporation, an
association, a partnership, a trust or estate, a government, foreign or
domestic, and any agency or political subdivision thereof, or any other entity.

         "PBGC" means the Pension Benefit Guaranty Corporation and any entity
succeeding to any or all of its functions under ERISA.

         "Plan" means, at any date, any employee pension benefit plan (as
defined in section 3(2) of ERISA) which is subject to Title IV of ERISA (other
than a Multiemployer Plan) and to which the Company or any ERISA Affiliate may
have any liability, including any liability by reason of having been a
substantial employer within the meaning of section 4063 of ERISA at any time
during the preceding five years, or by reason of being deemed to be a
contributing sponsor under section 4069 of ERISA.

         "Reportable Event" has the meaning assigned to such term in section
4043 of ERISA.

         "Subsidiaries"means any entity in which the Company, directly or
indirectly, owns 10% or more of the capital stock or holds an equity or similar
interest.

         ss.10.2. Accounting Terms. All accounting terms used herein which are
not expressly defined in this Agreement have the meanings respectively given to
them in accordance with

                                     - 32 -
<PAGE>

GAAP, all computations made pursuant to this Agreement shall be made in
accordance with GAAP, and all balance sheets and other financial statements
shall be prepared in accordance with GAAP.

         ss.11. EVENTS OF DEFAULT; REMEDIES.

         ss.11.1. Events of Default Defined. If any of the following events
(herein called "Events of Default") shall have occurred and be continuing
(whatever the reason for such Event of Default and whether it shall be voluntary
or involuntary or by operation of law or otherwise), that is to say:

                  (1) default shall be made in the due and punctual payment of
         all or any part of the principal of, or interest on, any Note; or

                  (2) any representation or warranty made by the Company in this
         Agreement, the Security Documents, the Note or any other Transaction
         Document, or in connection with the transactions contemplated herein,
         shall prove to have been false or incorrect when made;

                  (3) default shall be made in the performance or observance of
         any covenant, agreement or condition contained in Section 8 or 9 hereof
         and such default shall have continued for a period of 15 days after the
         Company has become aware thereof by notice or otherwise;

                  (4) default shall be made in the performance or observance of
         any covenant, agreement or condition contained in this Agreement and
         such default shall have continued for a period of 15 days after the
         Company has become aware thereof;

                  (5) any event shall occur or any condition shall exist in
         respect of any debt or other indebtedness of the Company (other than
         the Notes) or a Subsidiary in an aggregate unpaid principal amount of
         $100,000 or more, or under any agreement securing or relating to any of
         such Indebtedness, the effect of which is to cause (or permit any
         holder of such Indebtedness or a trustee to cause) the acceleration of
         the maturity of such Indebtedness or to require the repayment or
         repurchase of such indebtedness, or any such Indebtedness shall not
         have been paid at the final maturity date thereof (as renewed or
         extended if such Indebtedness shall have been renewed or extended);

                  (6) the Company or a Subsidiary shall (1) apply for or consent
         to the appointment of, or the taking of possession by, a receiver,
         custodian, trustee or liquidator of itself or of all or a substantial
         part of its property, (2) be generally

                                     - 33 -
<PAGE>

         unable to pay its debts as such debts become due, (3) make a general
         assignment for the benefit of its creditors, (4) commence a voluntary
         case under the Federal Bankruptcy Code (as now or hereafter in effect),
         (5) file a petition seeking to take advantage of any other law
         providing for the relief of debtors, (6) fail to controvert in a timely
         or appropriate manner, or acquiesce in writing to, any petition filed
         against it in an involuntary case under such Bankruptcy Code, (7) take
         any action under the laws of its jurisdiction of incorporation
         analogous to any of the foregoing, or (8) take any corporate action for
         the purpose of effecting any of the foregoing;

                  (7) a proceeding or case shall be commenced, without the
         application or consent of the Company or a Subsidiary in any court of
         competent jurisdiction, seeking (1) the liquidation, reorganization,
         dissolution, winding up, or composition or readjustment of its debts,
         (2) the appointment of a trustee, receiver, custodian, liquidator or
         the like of it or of all or any substantial part of its assets, or (3)
         similar relief in respect of it, under any law providing for the relief
         of debtors, and such proceeding or case shall continue undismissed, or
         unstayed and in effect, for a period of 45 days; or an order for relief
         shall be entered in an involuntary case under such Bankruptcy Code,
         against the Company or such Subsidiary; or action under the laws of the
         jurisdiction of incorporation of the Company or a Subsidiary analogous
         to any of the foregoing shall be taken with respect to the Company or
         such Subsidiary and shall continue unstayed and in effect for any
         period of 45 consecutive days;

                  (8) final judgment for the payment of money shall be rendered
         by a court of competent jurisdiction against the Company or a
         Subsidiary and the Company or such Subsidiary, as the case may be,
         shall not discharge the same or provide for its discharge in accordance
         with its terms, or procure a stay of execution thereof within 60 days
         from the date of entry thereof and within said period of 60 days, or
         such longer period during which execution of such judgment shall have
         been stayed, appeal therefrom and cause the execution thereof to be
         stayed during such appeal, and such judgment together with all other
         such judgments shall exceed in the aggregate $250,000; or

                  (9) Any Note, Security Document or other Transaction Document
         shall for any reason cease to be, or shall be asserted by the Company
         not to be, a legal, valid and binding obligation of the Company,
         enforceable in accordance with its terms, or the security interest or
         Lien purported to be created by any of the Security Documents shall for
         any reason cease to be, or be asserted by the Company not to be, a
         valid, perfected security interest in any Collateral (except to the
         extent otherwise permitted under any of the Security Documents); or

                                     - 34 -
<PAGE>

                  (10) The Company shall default and/or be in material breach of
         any term and/or provision in the Redemption Agreement or any other
         Transaction Document;

         then upon the occurrence of any Event of Default described above, the
Conversion Price shall be subject to reduction as provided in Section 1.5 above.
An Event of Default shall not, however, permit the holders of Notes to
accelerate the payment of the principal amount outstanding under the Notes, and
accrued interest thereon.

         ss.11.2. Suits for Enforcement. If any Event of Default shall have
occurred and be continuing, the holder of any Note may proceed to protect and
enforce its rights, either by suit in equity or by action at law, or both,
whether for the specific performance of any covenant or agreement contained in
this Agreement or in aid of the exercise of any power granted in this Agreement,
or the holder of any Note may proceed to enforce any other legal or equitable
right of the holder of such Note.

         The Company covenants that, if it shall default in the making of any
payment due under any Note or in the performance or observance of any agreement
contained in this Agreement, it will pay to the holder thereof such further
amounts, to the extent lawful, as shall be sufficient to pay the costs and
expenses of collection or of otherwise enforcing such holder's rights, including
reasonable counsel fees.

         ss.11.3. Remedies Cumulative. No remedy herein conferred upon the
Subscribers or the holder of any Note is intended to be exclusive of any other
remedy and each and every such remedy shall be cumulative and shall be in
addition to every other remedy given hereunder or now or hereafter existing at
law or in equity or by statute or otherwise.

         ss.11.4. Remedies Not Waived. No course of dealing between the Company
and any Subscriber or the holder of any Note and no delay or failure in
exercising any rights hereunder or under any Note in respect thereof shall
operate as a waiver of any of such Subscriber's rights or the rights of any
holder of such Note.

         ss.12. REGISTRATION, TRANSFER AND EXCHANGE OF NOTES. The Company will
keep at its principal executive office a note register in which, subject to such
reasonable regulations as it may prescribe, but at its expense (other than
transfer taxes, if any), it will provide for the registration and transfer of
Notes.

         The holder of any Note may, at such holder's option subject to Section
3.5, surrender the same for transfer or exchange at said office, or at the place
of payment named in such Note, accompanied in the case of a transfer by a
written instrument of transfer duly executed by the

                                     - 35 -
<PAGE>

holder thereof or by such holder's attorney duly authorized in writing. In case
any holder shall so request transfer or exchange of any Note, the Company at its
expense (other than transfer taxes, if any) will deliver in exchange therefor
one or more new Notes (in minimum denominations of $100,000, except to evidence
the entire unpaid principal amount of the Note so surrendered), as requested by
such holder, in the same aggregate principal amount as the Note so surrendered,
each dated the later of the date of, or the date to which interest has been paid
on, the Note so surrendered.

         The Company and any agent of the Company may treat the person in whose
name any Note is registered as the owner of such Note for the purpose of
receiving payment of the principal of, premium (if any) and interest on such
Note and for all other purposes whatsoever, whether or not such Note be overdue,
and prior to due presentment for registration of transfer, the Company shall not
be affected by notice to the contrary. If any Note shall have been transferred
to another holder pursuant to this Section and such holder shall have designated
in writing the address to which communications with respect to such Note shall
be mailed, all notices, certificates, requests, statements and other documents
required or permitted to be delivered to any holder of a Note by any provision
hereof shall be delivered to such holder.

         ss.13. LOST, ETC., NOTES. Upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of
any Note, and (in case of loss, theft or destruction) of indemnity satisfactory
to it, or (in the case of mutilation) upon surrender and cancellation of such
Note, the Company will make and deliver in lieu of such Note a new Note of the
same series in a like unpaid principal amount, dated the later of the date of,
or the date to which interest has been paid on, the Note in lieu of which such
new Note is made and delivered. In the case of any of the Subscribers or any
other institutional investor holder of any of the Notes, such Subscriber's or
such holder's own unsecured agreement of indemnity shall be deemed satisfactory
to the Company.

         ss.14. AMENDMENT AND WAIVER. (A) Any term, covenant, agreement or
condition of this Agreement or of the Notes may, with the consent of the
Company, be amended, or compliance therewith may be waived (either generally or
in a particular instance and either retroactively or prospectively), by one or
more substantially concurrent written instruments signed by the Noteholders
Committee, provided, however, that

                  (1) no such amendment or waiver shall

                           (1) change the principal of, or the rate of interest
                  on, any of the Notes,

                           (2) change the time of payment of the principal of or
                  of interest on, any of the Notes to another time in excess of
                  six months,

                                     - 36 -
<PAGE>

                           (3) modify any of the provisions of this Agreement or
                  of the Notes with respect to the payment thereof,

                           (4) change the percentage of Notes required with
                  respect to any such amendment or to effectuate any such
                  waiver, or

                           (5) modify any provision of this Section,

         without the consent of a majority of the holders of all the Notes at
         the time outstanding; and

         no such waiver shall extend to or affect any obligation not expressly
         waived or impair any right consequent thereon.

                  (2) Any amendment or waiver pursuant to Subsection (A) of this
         Section shall apply equally to all the holders of the Notes and shall
         be binding upon them, upon each future holder of any Note and upon the
         Company, in each case whether or not a notation thereof shall have been
         placed on any Note.

         ss.15. HOME OFFICE PAYMENT. Notwithstanding anything to the contrary in
this Agreement or the Notes, so long as any Subscriber or any nominee designated
by such Subscriber shall be the holder of any Note, the Company shall punctually
pay all amounts which become due and payable on such Note to at such
Subscriber's address set forth on the signature page hereto, or at such other
place and in such other manner as such Subscriber may designate by notice to the
Company, without presentation or surrender of such Note. Each Subscriber agrees
that prior to the sale, transfer or other disposition of any such Note, such
Subscriber will make notation thereon of the portion of the principal amount
paid or prepaid and the date to which interest has been paid thereon, or
surrender the same in exchange for a Note or Notes aggregating the same
principal amount as the unpaid principal amount of the Note so surrendered. The
Company agrees that the provisions of this Section shall inure to the benefit of
any other institutional investor holder of any Note that shall have agreed to
comply with the requirements of this Section.

         ss.16. LIABILITIES OF THE SUBSCRIBER. Neither this Agreement nor any
disposition of any of the Notes shall be deemed to create any liability or
obligation of any Subscriber or any other holder of any Note to enforce any
provision hereof or of any of the Notes for the benefit or on behalf of any
other person who may be the holder of any Note.

         ss.17. TAXES. The Company will pay all taxes (including interest and
penalties) which may be payable in respect of the execution and delivery of this
Agreement or of the execution and delivery (but not the transfer) of any of the
Notes or of any amendment of, or waiver or consent under or with respect to,
this Agreement or of any of the Notes and will save the

                                     - 37 -
<PAGE>

Subscribers and all subsequent holders of the Notes harmless against any loss or
liability resulting from nonpayment or delay in payment of any such tax. The
obligations of the Company under this Section shall survive the payment of the
Notes.

         ss.18. MISCELLANEOUS.

         ss.18.1. Certain Fees and Expenses. The Company also agrees to pay all
expenses incurred by each Subscriber (including counsel fees) in connection with
any amendment or requested amendment of, or waiver or consent or requested
waiver or consent under or with respect to, this Agreement or any of the Notes,
whether or not the same shall become effective. The Company also agrees that it
will pay, and will save each Subscriber and all subsequent holders of the Notes
harmless against, any loss or liability resulting from the nonpayment or delay
in payment of any placement fees and other obligations of the Company to pay any
agent or broker in connection with the transactions hereby contemplated. The
obligations of the Company under this Section shall survive the payment of the
Notes.

         ss.18.2. Indemnification. The Company hereby agrees to indemnify,
exonerate and hold each Subscriber, each other holder from time to time of any
Note, and each of their respective officers, directors, employees and agents
(collectively herein called the "Indemnitees" and individually called an
"Indemnitee") free and harmless from and against any and all actions, causes of
action, suits, losses, liabilities, damages and expenses, including, without
limitation, reasonable attorney's fees and disbursements (collectively herein
called the "Indemnified Liabilities"), incurred by the Indemnitees or any of
them as a result of, or arising out of, or relating to the transactions
contemplated hereby and any purchase of stock, merger, dividend or other
transaction financed in whole or in part directly or indirectly with proceeds of
any of the Notes, except for any such Indemnified Liabilities arising on account
of such Indemnitee's gross negligence or willful misconduct, and if and to the
extent that the foregoing undertaking may be unenforceable for any reason, the
Company hereby agrees to make the maximum contribution to the payment and
satisfaction of each of the Indemnified Liabilities which is permissible under
applicable law. The obligations of the Company under this Section shall survive
the payment of the Notes.

         ss.18.3. Board Designees. The Company agrees that by 6 PM eastern
standard time on July 7, 2000 the Company's Board of Directors shall consist of
seven directors which shall include three members designated by the Company (who
shall be reasonable acceptable to Commonwealth Associates), two members
designated by Commonwealth Associates and two members designated by the
Subscribers and the number of directors comprising the Board shall not increase
without the consent of Commonwealth Associates' Board designees. At least three
of the members of the Board of Directors collectively designated by Commonwealth
Associates and the Subscribers shall be "independent directors" (as such term is
defined in Rule 4200 of the Nasdaq Stock Market). Any director designated by
Commonwealth Associates or the Subscribers may be replaced at any time. In the
event that any director designated by Commonwealth Associates or the

                                     - 38 -
<PAGE>

Subscribers resigns or for any reason no longer serves as a director, then
Commonwealth Associates or the Subscribers, as the case may be, shall designate
a replacement for such director. In addition, in the event that any of the
parties does not exercise its respective right to designate a member or members
of the Board, then the failure to do so shall not constitute a waiver of such
right and such party may then appoint any person to be an observer who shall be
entitled to attend and observe meetings of the Board of Directors and any
committees thereof (and receive all notices, communications and other
information provided in connection with such meetings). The obligations of the
Company under this Section shall survive until such time as (i) all of the
outstanding Notes have converted into Common Stock pursuant to optional
conversion features set forth in the Note or (ii) at least 90% of the
outstanding C Preferred Shares have converted into Common Stock pursuant to the
terms of the conversion features set forth in the C Designation.

         ss.18.4. Further Assurances. From time to time, as and when requested
by any party hereto and at such party's expense, either before or after Closing,
any other party shall execute and deliver, or cause to be executed and
delivered, all such documents and instruments and shall take, or cause to be
taken, all such further or other actions as such other party may reasonably deem
necessary or desirable to evidence and effectuate the transactions contemplated
by this Agreement and the other Transaction Documents.

         ss.18.5. Reliance on and Survival of Representations. All agreements,
representations and warranties of the Company herein and in any certificates or
other instruments delivered pursuant to this Agreement shall (A) be deemed to be
material and to have been relied upon by each of the Subscribers,
notwithstanding any investigation heretofore or hereafter made by the
Subscribers or on their behalf, and (B) survive the execution and delivery of
this Agreement and the delivery of the Notes to each of the Subscribers, and
shall continue in effect so long as any Note is outstanding and thereafter as
provided in ss.ss.17, 18.1 and 18.2.

         ss.18.6. Successors and Assigns. This Agreement shall bind and inure to
the benefit of and be enforceable by the Company and its permitted successors
and assigns hereunder, each of the Subscribers and their successors and assigns,
and, in addition, shall inure to the benefit of and be enforceable by all
holders, from time to time, of the Notes; provided, however, that the benefit of
ss.ss.6, 7, 12 (as to satisfactory indemnity) and 14 shall be limited as
provided therein;

         ss.18.7. Communications. All communications and notices provided for
herein shall be in writing and shall be sent by confirmed telecopy with machine
generated transmittal confirmation, hand delivered (with confirmation of
receipt) prepaid national recognized overnight courier service (with
confirmation of receipt) or mailed by first class mail, postage prepaid, and
addressed as follows:

                  (1) if to the Company, at the address set forth at the head of
         this Agreement,

                                     - 39 -
<PAGE>

                  (2) if to the Subscribers, to the appropriate address(es) set
         forth on the signature page hereto, and

                  (3) if to any other Person who is the registered holder of an
         outstanding Note, to the address for the purposes of such holder as it
         appears on the note register.

         The address for any purpose hereof of the Company may be changed at any
time and from time to time and shall be the most recent such address furnished
in writing by the Company to the Subscribers and to each other Person who is the
registered holder of any outstanding Note. The address for any purpose hereof of
any Subscriber or of any other Person who is the registered holder of any
outstanding Note may be changed at any time and from time to time and shall be
the most recent such address furnished in writing by such Subscriber or by such
other Person, as the case may be, to the Company.

         Any notice or other communication herein provided to be given to the
holders of all outstanding Notes shall be deemed to have been duly given (i) on
the date of any such facsimile transmission or hand delivery of such notice or
other communications, (ii) two days after any such notice or communications is
provided to a nationally recognized overnight courier service or (iii) five days
after any such notice or communication is mailed by first class mail, if sent as
aforesaid to each of the registered holders of the Notes at the time outstanding
at the address for such purpose of such holder as it appears on the note
register.

         ss.18.8. Governing Law. This Agreement and the Notes and (unless
otherwise provided) all amendments, supplements, waivers and consents relating
hereto or thereto shall be construed in accordance with and governed by the laws
of the State of New York.

         ss.18.9. Voidability for Florida Residents. The sale of Notes and
Warrants hereunder to residents of Florida is voidable at the election of a
Subscriber within three days after the first tender of consideration is made by
such Subscriber or within three days after the availability of that privilege
has been communicated to such Subscriber, whichever occurs later. The
undersigned hereby acknowledges that the Company has communicated to it the
availability of the privilege to void the sale hereunder as of the date hereof.

         ss.18.10. JURISDICTION AND PROCESS; WAIVER OF JURY TRIAL. THE COMPANY
AGREES THAT ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE NOTES OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION HEREWITH, OR
ANY LEGAL ACTION OR PROCEEDING TO EXECUTE OR OTHERWISE ENFORCE ANY JUDGMENT
OBTAINED AGAINST THE COMPANY FOR BREACH HEREOF OR THEREOF, OR AGAINST ANY OF ITS
PROPERTIES,

                                     - 40 -
<PAGE>

MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES
DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK BY YOU OR ON YOUR BEHALF OR
BY OR ON BEHALF OF ANY HOLDER OF A NOTE, AS YOU OR SUCH HOLDER MAY ELECT, AND
THE COMPANY HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS TO THE NON-EXCLUSIVE
JURISDICTION OF SUCH COURTS FOR PURPOSES OF ANY SUCH LEGAL ACTION OR PROCEEDING.
IN ADDITION, THE COMPANY HEREBY IRREVOCABLY WAIVES TO THE FULLEST EXTENT
PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING
OF VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE NOTES OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION HEREWITH
BROUGHT IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES DISTRICT
COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND ANY CLAIM THAT ANY SUCH SUIT,
ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN
INCONVENIENT FORUM.

         THE COMPANY FURTHER WAIVES TRIAL BY JURY IN ANY ACTION BROUGHT ON OR
WITH RESPECT TO THIS AGREEMENT OR THE NOTES OR ANY OTHER DOCUMENT EXECUTED IN
CONNECTION HEREWITH.

         ss.18.11. Counterparts. This Agreement may be executed in counterparts,
each of which shall be deemed an original but all of which together shall
constitute one and the same instrument. In the event that any signature is
permitted by the recipient to be delivered by facsimile transmission, such
signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if
such facsimile signature page were an original thereof.

         ss.18.12. Headings. The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect any of the terms
hereof.

                                     - 41 -
<PAGE>

          IN WITNESS WHEREOF, the parties have executed this Subscription
Agreement as of the day and year first written above.

SUBSCRIBER**:                             CO-SUBSCRIBER**:

------------------------------------      --------------------------------------
Signature of Subscriber                   Signature of Co-Subscriber

------------------------------------      --------------------------------------
Name of Subscriber [please print]         Name of Co-Subscriber [please print]

------------------------------------      --------------------------------------
Address of Subscriber                     Address of Co-Subscriber

------------------------------------      --------------------------------------
Social Security or Taxpayer               Social Security or Taxpayer
Identification Number of Subscriber       Identification Number of Co-Subscriber

-----------------------------------------------------
Name of Holder(s) as it should appear on the security certificates*
[please print]

* Please provide the exact names that you wish to see on the certificates
(1)      For individuals, print full name of subscriber.
(2)      For joint, print full name of subscriber and all co-subscribers.
(3)      For corporations, partnerships, LLC, print full name of entity,
         including "&", "Co.", "Inc.", "etc", "LLC", "LP", etc.
(4)      For Trusts, print trust name (please contact your trustee for the exact
         name that should appear on the certificates.)
(5)      For IRA account maintained at Commonwealth, print "Wexford Clearing
         Corp as C/F".

LRX-                                      Subscription Accepted:
------------------------------------      ProxyMed, Inc.
Subscriber's Account Number at
Commonwealth Associates, if applicable
                                          By:
                                             -----------------------------------
Dollar Amount of Units Subscribed For:       Name:
                                             Title:
$
 -------------------
                                          $
                                           -------------------------------------
                                           Amount of Unit Subscription Accepted

** If Subscriber is a Registered              The undersigned NASD member firm
Representative with an NASD member            acknowledges receipt of the notice
firm or an affiliated person of an            required by Rule 3040 of the NASD
NASD member firm, have the                    Conduct Rules.
acknowledgment to the right signed
by the appropriate party:

                                          --------------------------------------
                                          Name of NASD Member Firm

                                          By:
                                             -----------------------------------
                                             Authorized Officer

                                     - 42 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}]]